Emeritus Professor John Chalmers

AC
Emeritus Professor
Medicine, Central Clinical School

Telephone +61 2 9993 4587
Fax +61 2 9993 4588

Map

Research interests

Large scale clinical trials and epidemiological studies in relation to hypertension, to coronary heart disease and stroke, and to diabetes and renal disease. Particular focus on international studies that include low and middle income countries as well as countries with advanced economies.

Selected grants

2014

  • Discovery and translation of evidence for new strategies to combat cardiovascular diseases; MacMahon S, Chalmers J, Neal B, Woodward M, Anderson C, Patel A, Rodgers A, Perkovic V; National Health and Medical Research Council (NHMRC)/Program Grants.

2012

  • Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED); Anderson C, Chalmers J, Lindley R, Arima H, Wang J, Levi C; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Reducing Salt in the Australian Diet; Neal B, Nowson C, Chalmers J, Smith W, Flood V, Nowson, C, Woodward M, Szabo L; National Health and Medical Research Council (NHMRC)/Partnership Projects.

2009

  • Using health economics to strengthen ties between evidence, policy and practice in chronic disease; Jan S, Clarke P, Howard K, Salkeld G, Chalmers J, Leeder S; National Health and Medical Research Council (NHMRC)/Strategic Awards: Capacity Building Grants for Health Services Research.
  • Generating the evidence for new strategies to combat cardiovascular diseases.; MacMahon S, Chalmers J, Neal B, Woodward M, Anderson C, Patel A; National Health and Medical Research Council (NHMRC)/Program Grants.

2008

  • INTERACT: a randomised trial of intensive blood pressure lowering in acute intracerebral haermorrhage; Anderson C, Wang J, Chalmers J, Wang J, Lindley R; National Health and Medical Research Council (NHMRC)/Project Grants.

2005

  • New evidence to guide decisions about the prevention and treatment of common cardiovascular diseases; MacMahon S, Croft K, Chalmers J, Neal B, Anderson C, Woodward M, Croft K; National Health and Medical Research Council (NHMRC)/Program Grants.

2003

  • The blood pressure lowering treatment trialists collaboration; Neal B, MacMahon S, Chalmers J, Chapman N, Woodward M; National Health and Medical Research Council (NHMRC)/Project Grants.

2002

  • Internal Research Support Chalmers - CHS; Chalmers J; University of Sydney/Internal Research Grant Allocations - Medicine.
  • A factorial randomised trial of intensive blood pressure lowering and glucose control in subjects with type 2 diabetes; MacMahon S, Chalmers J, Neal B, Woodward M; National Health and Medical Research Council (NHMRC)/Clinical Trial Large Scale (CTLS).

2001

  • WHO-ISH BP blood pressure lowering treatment trialists collaboration; Neal B, MacMahon S, Chalmers J; National Health and Medical Research Council (NHMRC)/Project Grants.

2000

  • Functional specificity of bulbospinal pathways regulating blood pressure; Pilowsky P, Chalmers J; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Servier Clinical Trial Agreement (including variation to the agreement between the Uni of Syd, ADIR & The Institut de Recherches Int Servier); Kramer D, Dowell G, Monaghan H, Sowden K, Pracy M, MacMahon S, MacMahon S, Chalmers J; Servier/Research Grants.
  • WHO-ISH blood pressure lowering treatment trialists collaboration; MacMahon S, Chalmers J, Neal B; Heart Foundation of Australia/Grants-in-Aid.
  • Central inhibitory neurons in experimental hypertension; Pilowsky P, Chalmers J, Goodchild A; Heart Foundation of Australia/Grants-in-Aid.

1999

  • NHMRC 990846 MacMahon; Neal B, Chalmers J, MacMahon S; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Chalmers, J., Colagiuri, S., Cooper, M., Grobbee, R., Hamet, P., Kengne, A., MacMahon, S., Marre, M., Mogensen, C., Neal, B., Patel, A., Perkovic, V., et al (2008). Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR. France: Wolters Kluwer Health France.
  • Chalmers, J. (2007). ADVANCE: New Approaches for the prevention of Vascular Disease in Type 2 Diabetes. Issue 1. France: Wolters Kluwer Health France.

Edited Books

  • Chalmers, J., Colagiuri, S., Grobbee, R., Hamet, P., Kengne, A., MacMahon, S., Mogensen, C., Neal, B., Patel, A., Perkovic, V., et al (2007). New approaches for the prevention of vascular disease in type 2 diabetes: benefits of blood pressure lowering with the fixed combination of perindopril and indapamide. France: Wolters Kluwer Health Pharma Solutions.
  • Chalmers, J., MacMahon, S., Brass, L., Chapman, N., Gorelick, P., Neal, B. (2002). Clinician's Manual on Blood Pressure and Stroke Prevention. United Kingdom: Current Medicine Group Ltd.

Book Chapters

  • Chapman, N., Arima, H., Chalmers, J., Anderson, C. (2012). Cerebrovascular Disease in Hypertension. In Henry R Black and William J Elliott (Eds.), Hypertension: A Companion to Braunwald's Heart Disease, Second Edition, (pp. 303-312). Philadelphia: Elsevier.
  • Hata, J., Arima, H., Anderson, C., Chalmers, J. (2012). Cognitive Function and Dementia in Hypertension: Epidemiologic and Therapeutic Aspects. In Adel E. Berbari and Giuseppe Mancia (Eds.), Special Issues in Hypertension, (pp. 399-412). Milan, Italy: Springer.
  • Chalmers, J., Cooper, M., Grobbee, R., Hamet, P., Kengne, A., MacMahon, S., Marre, M., Mogensen, C., Neal, B., Patel, A., et al (2010). Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure Peterax and Diamicron MR. In J Chalmers (Eds.), Action in Diabetes and Vascular Disease: Preterax and Diamicron Mr Controlled Evaluation. France: Wolters Kluwer Health France.
  • Perkovic, V., Ninomiya, T., MacMahon, S., Chalmers, J. (2009). Renal and microalbuminuria data from ADVANCE. In Bernard I. Levy, Harry A.J. Struijker-Boudier (Eds.), Role of Macro and Microcirculation in Target Organ Damage in Diabetes and Hypertension, (pp. 121-132). West Sussex: Wiley-Blackwell Publishing.
  • Chalmers, J. (2008). Prevention of stroke and major cardiovascular events with perindopril-based treatment: the PROGRESS trial. In R. Ferrari and K. M. Fox (Eds.), Perindopril: a major contribution to the prevention and treatment of cardiovascular disease, (pp. 47-58). France: Wolters Kluwer Health Pharma Solutions.
  • Chalmers, J., Turnbull, F. (2006). Blood Pressure Lowering in Patients with a Previous Stroke. In Mohler E; Townsend R (Eds.), Advanced Therapy in Hypertension and Vascular Disease, (pp. 130-135). Ontario, Canada: BC Decker Inc.
  • Chapman, N., Anderson, C., Chalmers, J. (2006). Cerebrovascular Disease in Hypertension. In Henry R. Black, William J. Elliott (Eds.), Hypertension: A Companion to Braunwald's Heart Disease, (pp. 392-405). Saunders Elsevier.
  • Chalmers, J., Chapman, N. (2004). Development Of Blood Pressure Lowering Therapy: From Trials To Practice. In WH Birkenhager, JIS Robertson, A Zanchetti (Eds.), Hypertension in the Twentieth Century: Concepts and Achievements; Handbook of Hypertension, (pp. 504-525). Amsterdam, The Netherlands: Elsevier.
  • Chalmers, J., Morniroli, J. (2004). The Kidney and Hypertension in Diabetes Mellitus. In Carl Erik Mogensen (Eds.), Blood Pressure Lowering Treatment And The Prevention Of Stroke In The Diabetic Patient, (pp. 611-630). London: Taylor and Francis.
  • Chalmers, J., MacMahon, S., Currie, R. (2003). PROGRESS: Rationale, results and importance: Perspective from the Principle Investigators. In Teruo Omae (Eds.), How to conduct large-scaled clinical trials in Japan, (pp. 51-55). Japan: Nihon Iji Shinpo.

Journals

  • Fischer, U., Cooney, M., Bull, L., Silver, L., Chalmers, J., Anderson, C., Mehta, Z., Rothwell, P. (2014). Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. Lancet Neurology, 13(4), 374-384. [More Information]
  • Zheng, D., Arima, H., Heeley, E., Karpin, A., Heller, G., Yang, J., Chalmers, J., Anderson, C. (2014). Ambient Temperature and Severity of Intracerebral Haemorrhage: The INTERACT1 Study. Neuroepidemiology, 42(3), 169-173. [More Information]
  • Manning, L., Hirakawa, Y., Arima, H., Wang, X., Chalmers, J., Wang, J., Lindley, R., Heeley, E., Delcourt, C., Neal, B., Woodward, M., Anderson, C., et al (2014). Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurology, 13(4), 364-373. [More Information]
  • Lowe, G., Woodward, M., Hillis, G., Rumley, A., Li, Q., Harrap, S., Marre, M., Hamet, P., Patel, A., Poulter, N., Chalmers, J. (2014). Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study. Diabetes, 63(3), 1115-1123. [More Information]
  • Weber, M., Schiffrin, E., White, W., Mann, S., Lindholm, L., Kenerson, J., Flack, J., Carter, B., Materson, B., Ram, C., Chalmers, J., et al (2014). Clinical Practice Guidelines for the Management of Hypertension in the Community. A Statement by the American Society of Hypertension and the International Society of Hypertension. Journal of Hypertension, 32(1), 3-15. [More Information]
  • Chalmers, J., Arima, H., Woodward, M., Mancia, G., Poulter, N., Hirakawa, Y., Zoungas, S., Patel, A., Williams, B., Harrap, S. (2014). Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial. Hypertension, 63(2), 259-264. [More Information]
  • Van Dieren, S., Kengne, A., Chalmers, J., Beulens, J., Davis, T., Fulcher, G., Heller, S., Patel, A., Colagiuri, S., Hamet, P., Neal, B., Woodward, M., Zoungas, S., et al (2014). Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial. Diabetes, Obesity and Metabolism, 16(5), 426-432. [More Information]
  • Land, M., Jeffery, P., Webster, J., Crino, M., Chalmers, J., Woodward, M., Nowson,, C., Smith, W., Flood, V., Neal, B. (2014). Protocol for the implementation and evaluation of a community-based intervention seeking to reduce dietary salt intake in Lithgow, Australia. BMC Public Health, 14(1), 1-7. [More Information]
  • Ding, M., Rogers, K., Macniven, R., Kamalesh, V., Kritharides, L., Chalmers, J., Bauman, A. (2014). Revisiting Lifestyle Risk Index Assessment in a Large Australian Sample: Are Sedentary Behavior and Sleep Correlated with Health Outcomes. Preventive Medicine, 60, 102-106. [More Information]
  • Land, M., Webster, J., Christofolou, A., Praveen, D., Jeffery, P., Chalmers, J., Smith, W., Woodward, M., Barzi, F., Nowson,, C., Neal, B., et al (2014). Salt intake assessed by 24 h urinary sodium excretion in a random and opportunistic sample in Australia. BMJ Open, 4(2), 1-7. [More Information]
  • Chen, G., Arima, H., Wu, G., Heeley, E., Delcourt, C., Zhang, P., Rabinstein, A., Robinson, T., Stapf, C., Huang, Y., Song, L., Yang, J., Wang, X., Li, Q., Chen, X., Chalmers, J., Anderson, C. (2014). Subarachnoid Extension of Intracerebral Hemorrhage and 90-Day Outcomes in INTERACT2. Stroke, 45(1), 258-260. [More Information]
  • Land, M., Webster, J., Christofolou, A., Johnson, C., Trevena, H., Hodgins, F., Chalmers, J., Woodward, M., Barzi, F., Smith, W., Flood, V., Neal, B., et al (2014). The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion. The International Journal of Behavioral Nutrition and Physical Activity, 11(1), 1-8. [More Information]
  • Hillis, G., Welsh, P., Chalmers, J., Perkovic, V., Chow, C., Li, Q., Jun, M., Neal, B., Zoungas, S., Poulter, N., Woodward, M., et al (2014). The relative and combined ability of high sensitivity cardiac troponin T and N-terminal pro-BNP to predict cardiovascular events and death in patients with type 2 diabetes mellitus. Diabetes Care, 37(1), 295-303. [More Information]
  • Rist, P., Chalmers, J., Arima, H., Anderson, C., MacMahon, S., Woodward, M., Kurth, T., Tzourio, C. (2013). Baseline Cognitive Function, Recurrent Stroke, and Risk of Dementia in Patients With Stroke. Stroke, 44(7), 1790-1795. [More Information]
  • Ninomiya, T., Perkovic, V., Turnbull, F., Neal, B., Barzi, F., Cass, A., Baigent, C., Chalmers, J., Li, N., Woodward, M., MacMahon, S. (2013). Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ, 347(7929), 1-15. [More Information]
  • Wong, M., Perkovic, V., Woodward, M., Chalmers, J., Li, Q., Hillis, G., Azari, E., Jun, M., Poulter, N., Hamet, P., Neal, B., Pollock, C., et al (2013). Circulating bone morphogenetic protein-7 and transforming growth factor-(beta)1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney International, 83(2), 278-284. [More Information]
  • Chalmers, J. (2013). Current issues with dual inhibition of the renin-angiotensin system. Journal of Hypertension, 31(2), 261-262. [More Information]
  • Hata, J., Arima, H., Zoungas, S., Fulcher, G., Pollock, C., Adams, M., Watson, J., Joshi, R., Kengne, A., Ninomiya, T., Anderson, C., Woodward, M., Patel, A., MacMahon, S., Chalmers, J., Neal, B., et al (2013). Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial. PLoS One, 8(2), 1-7. [More Information]
  • Hata, J., Arima, H., Rothwell, P., Woodward, M., Zoungas, S., Anderson, C., Patel, A., Neal, B., Glasziou, P., Hamet, P., MacMahon, S., Chalmers, J., et al (2013). Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The ADVANCE trial. Circulation, 128(12), 1325-1334. [More Information]
  • Banks, E., Joshy, G., Abhayaratna, W., Kritharides, L., MacDonald, P., Korda, R., Chalmers, J. (2013). Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort Study. PLoS Medicine, 10(1), 1-13. [More Information]
  • Chalmers, J., Arima, H., Harrap, S., Touyz, R., Park, J. (2013). Global survey of current practice in management of hypertension as reported by societies affiliated with the international society of hypertension. Journal of Hypertension, 31(5), 1043-1048. [More Information]
  • Perkovic, V., Heerspink, H., Chalmers, J., Woodward, M., Jun, M., Li, Q., MacMahon, S., Cooper, M., Hamet, P., Marre, M., Cass, A., Patel, A., Zoungas, S., et al (2013). Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney International, 83(3), 517-523. [More Information]
  • Batty, G., Li, Q., Huxley, R., Zoungas, S., Taylor, B., Neal, B., de Galan, B., Woodward, M., Harrap, S., Colagiuri, S., Patel, A., Chalmers, J. (2013). Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. European Psychiatry, 28(1), 49-52. [More Information]
  • Chalmers, J., Angus, J., Graham, R., Carmody, J., Dampney, R., Jennings, G., Korner, N. (2013). Paul Ivan Korner 1925-2012. Historical Records of Australian Science, 24(2), 251-282. [More Information]
  • Anderson, C., Heeley, E., Huang, Y., Wang, J., Stapf, C., Delcourt, C., Lindley, R., Robinson, T., Lavados, P., Neal, B., Hata, J., Arima, H., Heritier, S., Li, Q., Woodward, M., Simes, R., Chalmers, J., et al (2013). Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage. The New England Journal of Medicine, 368(25), 2355-2365. [More Information]
  • Anderson, C., Heeley, E., Heritier, S., Arima, H., Woodward, M., Lindley, R., Neal, B., Huang, Y., Wang, J., Parsons, M., Delcourt, C., Chalmers, J., et al (2013). Statistical analysis plan for the second INTEnsive blood pressure Reduction in Acute Cerebral hemorrhage Trial (INTERACT2): a large-scale investigation to solve longstanding controversy over the most appropriate management of elevated blood pressure in the hyperacute phase of intracerebral hemorrhage. International Journal of Stroke, 8(5), 327-328. [More Information]
  • Morton, J., Ng, M., Chalmers, J., Woodward, M., Mancia, G., Poulter, N., Marre, M., Cooper, M., Zoungas, S. (2013). The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? Cancer Epidemiology, Biomarkers and Prevention, 22(9), 1628-1633. [More Information]
  • Perkovic, V., Woodward, M., Zoungas, S., Chalmers, J. (2013). The authors reply Caution advised in interpreting nonsignificant results from ADVANCE post hoc analysis. Kidney International, 84(3), 622-622. [More Information]
  • Justin Zaman, M., Patel, A., Chalmers, J., Woodward, M., Clarke, P., Li, Q., Zoungas, S. (2013). The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes. Diabetic Medicine, 30(8), 918-925. [More Information]
  • Blomster, J., Chow, C., Zoungas, S., Woodward, M., Patel, A., Poulter, N., Marre, M., Harrap, S., Chalmers, J., Hillis, G. (2013). The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, 15(11), 1008-1012. [More Information]
  • Stefansdottir, G., Zoungas, S., Chalmers, J., Knol, M., Leufkens, H., Woodward, M., Patel, A., Grobbee, D., De Bruin, M. (2013). The Post Hoc Use of Randomised Controlled Trials to Explore Drug Associated Cancer Outcomes: Methodological Challenges. Current Drug Safety, 8(5), 371-378. [More Information]
  • Zoungas, S., Chalmers, J., Li, Q., Woodward, M. (2012). ADVANCE and glycaemia thresholds: a need to clarify the statistical approach. Reply to Currie CJ [letter]. Diabetologia: clinical and experimental diabetes and metabolism, 55(8), 2300-2300. [More Information]
  • Zoungas, S., Chalmers, J., Ninomiya, T., Li, Q., Cooper, M., Colagiuri, S., Fulcher, G., de Galan, B., Harrap, S., Hamet, P., Patel, A., Neal, B., Woodward, M., et al (2012). Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia: clinical and experimental diabetes and metabolism, 55(3), 636-643. [More Information]
  • Fox, C., Matsushita, K., Woodward, M., Bilo, H., Chalmers, J., Heerspink, H., Lee, B., Perkins, R., Rossing, P., Sairenchi, T., et al (2012). Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. The Lancet, 380(9854), 1662-1673. [More Information]
  • Razavian, M., Heeley, E., Perkovic, V., Zoungas, S., Weekes, A., Patel, A., Anderson, C., Chalmers, J., Cass, A. (2012). Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrology, Dialysis, Transplantation, 27(4), 1396-1402. [More Information]
  • Chalmers, J., Arima, H., Hata, J. (2012). Cost-effective reduction in stroke: lessons from the Japanese hypertension detection and control program. Journal of Hypertension, 30(9), 1706-1707. [More Information]
  • Heeley, E., Anderson, C., Patel, A., Cass, A., Peiris, D., Weekes, A., Chalmers, J. (2012). Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice. International Journal of Stroke, 7(8), 649-654. [More Information]
  • Arima, H., Huang, Y., Wang, J., Heeley, E., Delcourt, C., Parsons, M., Li, Q., Neal, B., Chalmers, J., Anderson, C. (2012). Earlier Blood Pressure-Lowering and Greater Attenuation of Hematoma Growth in Acute Intracerebral Hemorrhage: INTERACT Pilot Phase. Stroke, 43(8), 2236-2238. [More Information]
  • Van Dieren, S., Kengne, A., Chalmers, J., Beulens, J., Cooper, M., Grobbee, D., Harrap, S., Mancia, G., Neal, B., Patel, A., Woodward, M., Zoungas, S., et al (2012). Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. Diabetes Research and Clinical Practice, 98(1), 83-90. [More Information]
  • Arima, H., Anderson, C., Omae, T., Woodward, M., MacMahon, S., Mancia, G., Bousser, M., Tzourio, C., Rodgers, A., Neal, B., Chalmers, J. (2012). Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial. Stroke, 43(6), 1675-1677. [More Information]
  • Lv, J., Neal, B., Ehteshami, P., Ninomiya, T., Woodward, M., Rodgers, A., Wang, H., MacMahon, S., Turnbull, F., Hillis, G., Chalmers, J., Perkovic, V. (2012). Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Medicine, 9(8), 1-14. [More Information]
  • Salvi, E., Kutalik, Z., Glorioso, N., Benaglio, P., Frau, F., Kuznetsova, T., Arima, H., Hoggart, C., Tichet, J., Nikitin, Y., Chalmers, J., et al (2012). Genomewide Association Study Using a High-Density Single Nucleotide Polymorphism Array and Case-Control Design Identifies a Novel Essential Hypertension Susceptibility Locus in the Promoter Region of Endothelial NO Synthase. Hypertension, 59(2), 248-255. [More Information]
  • Zoungas, S., Chalmers, J. (2012). Glycemic control and outcomes in people with diabetes and CKD. Nature Reviews Nephrology, 8(3), 133-134. [More Information]
  • Delcourt, C., Huang, Y., Arima, H., Chalmers, J., Davis, S., Heeley, E., Wang, J., Parsons, M., Liu, G., Anderson, C. (2012). Hematoma growth and outcomes in intracerebral hemorrhage: The INTERACT1 study. Neurology, 79(4), 314-319. [More Information]
  • Knott, R., Cass, A., Heeley, E., Chalmers, J., Pieris, D., Clarke, P. (2012). How fair is Medicare? The income-related distribution of Medicare benefits with special focus on chronic care items. Medical Journal of Australia, 197(11/12), 1-5. [More Information]
  • Morton, J., Zoungas, S., Li, Q., Patel, A., Chalmers, J., Woodward, M., Celermajer, D., Beulens, J., Stolk, R., Glasziou, P., Ng, M. (2012). Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study. Diabetes Care, 35(11), 2201-2206. [More Information]
  • Chalmers, J. (2012). Making Good Use of Diastolic and Systolic Blood Pressures in the Management of Hypertension. Hypertension, 60(5), 1110-1111. [More Information]
  • Kengne, A., Sobngwi, E., Chalmers, J. (2012). Multiple risk factor interventions and inflammatory biomarkers in high risk individuals with type 2 diabetes. Diabetes Research and Clinical Practice, 95(3), 386-388. [More Information]
  • Jardine, M., Hata, J., Woodward, M., Perkovic, V., Ninomiya, T., Arima, H., Zoungas, S., Cass, A., Patel, A., Marre, M., Chalmers, J., et al (2012). Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes. American Journal of Kidney Diseases, 60(5), 770-778. [More Information]
  • Hillis, G., Woodward, M., Rodgers, A., Chow, C., Li, Q., Zoungas, S., Patel, A., Webster, R., Batty, G., Ninomiya, T., Chalmers, J., et al (2012). Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia: clinical and experimental diabetes and metabolism, 55(5), 1283-1290. [More Information]
  • Hillis, G., Hata, J., Woodward, M., Perkovic, V., Arima, H., Chow, C., Zoungas, S., Patel, A., Poulter, N., Mancia, G., Chalmers, J., et al (2012). Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus. Journal of the American Heart Association, 1(5), 1-11. [More Information]
  • Wong, G., Zoungas, S., Lo, S., Chalmers, J., Cass, A., Neal, B., Woodward, M., Perkovic, V., Glasziou, P., Williams, B., Howard, K., Chapman, J., Craig, J. (2012). The risk of cancer in people with diabetes and chronic kidney disease. Nephrology, Dialysis, Transplantation, 27(8), 3337-3344. [More Information]
  • Van Dieren, S., Czernichow, S., Chalmers, J., Kengne, A., de Galan, B., Poulter, N., Woodward, M., Beulens, J., Grobbee, D., van der Schouw, Y., Zoungas, S. (2012). Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial. Diabetes, Obesity and Metabolism, 14(5), 464-469. [More Information]
  • Brugts, J., Isaacs, A., de Maat, M., Boersma, E., van Duijn, C., Akkerhuis, K., Uitterlinden, A., Witteman, J., Cambien, F., Ceconi, C., Ninomiya, T., Chalmers, J., MacMahon, S., et al (2011). A Pharmacogenetic Analysis of Determinants of Hypertension and Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Vascular Disease and Healthy Individuals. Journal of Hypertension, 29(3), 509-519. [More Information]
  • Salomon, J., Patel, A., Neal, B., Glasziou, P., Grobbee, D., Chalmers, J., Clarke, P. (2011). Comparability of Patient-reported Health Status: Multicountry Analysis of EQ-5D Responses in Patients With Type 2 Diabetes. Medical Care, 49(10), 962-969. [More Information]
  • Czernichow, S., Kengne, A., Huxley, R., Batty, G., de Galan, B., Grobbee, D., Pillai, A., Zoungas, S., Marre, M., Woodward, M., Neal, B., Chalmers, J. (2011). Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE. European Journal of Cardiovascular Prevention and Rehabilitation, 18(2), 312-319. [More Information]
  • Kengne, A., Patel, A., Marre, M., Travert, F., Lievre, M., Zoungas, S., Chalmers, J., Colagiuri, S., Grobbee, D., Hamet, P., Neal, B., Woodward, M., et al (2011). Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. European Journal of Cardiovascular Prevention and Rehabilitation, 18(3), 393-398. [More Information]
  • Woodward, M., Patel, A., Zoungas, S., Liu, L., Pan, C., Poulter, N., Januszewicz, A., Tandon, N., Joshi, P., Heller, S., Neal, B., Chalmers, J. (2011). Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial. Diabetes Care, 34(12), 2491-2495. [More Information]
  • Arima, H., Anderson, C., Omae, T., Woodward, M., Hata, J., Murakami, Y., MacMahon, S., Neal, B., Chalmers, J., PROGRESS Collaborative Group, -. (2011). Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial. Stroke, 42(8), 2339-2341. [More Information]
  • Turnbull, F., Arima, H., Heeley, E., Cass, A., Chalmers, J., Morgan, C., Patel, A., Peiris, D., Weekes, A., Anderson, C. (2011). Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study. European Journal of Cardiovascular Prevention and Rehabilitation, 18(3), 498-503. [More Information]
  • Stefansdottir, G., Zoungas, S., Chalmers, J., Kengne, A., Knol, M., Leufkens, H., Patel, A., Woodward, M., Grobbee, D., De Bruin, M. (2011). Intensive glucose control and risk of cancer in patients with type 2 diabetes. Diabetologia: clinical and experimental diabetes and metabolism, 54(7), 1608-1614. [More Information]
  • Chalmers, J. (2011). Is a Blood Pressure Target of <130/80 mm Hg Still Appropriate for High-Risk Patients? Circulation, 124(16), 1700-1702. [More Information]
  • Lee, P., Kengne, A., Greenfield, J., Day, R., Chalmers, J., Ho, K. (2011). Metabolic sequelae of beta-blocker therapy: weighing in on the obesity epidemic? International Journal of Obesity, 35(11), 1395-1403. [More Information]
  • Arima, H., Barzi, F., Chalmers, J. (2011). Mortality patterns in hypertension. Journal of Hypertension, 29(SUPPL. 1), S3-S7. [More Information]
  • Chalmers, J., Kengne, A. (2011). Predictive factors in assessing cardiovascular risk: learning from ADVANCE. Medicographia, 33(1), 47-51.
  • Arima, H., Chalmers, J. (2011). PROGRESS: Prevention of recurrent stroke. Journal of Clinical Hypertension, 13(9), 693-702. [More Information]
  • Hackam, D., Woodward, M., Newby, L., Bhatt, D., Shao, M., Smith, E., Donner, A., Muhammad, M., Douketis, J., Arima, H., Chalmers, J., MacMahon, S., et al (2011). Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-analysis. Circulation, 124(20), 2233-2242. [More Information]
  • Arima, H., Chalmers, J. (2011). Stroke: Blood pressure lowering in acute stroke-scant joy from SCAST. Nature Reviews Cardiology, 8(7), 366-368. [More Information]
  • Czernichow, S., Zanchetti, A., Turnbull, F., Barzi, F., Ninomiya, T., Kengne, A., Heerspink, H., Perkovic, V., Huxley, R., Arima, H., Patel, A., Chalmers, J., Woodward, M., MacMahon, S., Neal, B. (2011). The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. Journal of Hypertension, 29(1), 4-16. [More Information]
  • Jardine, M., Ninomiya, T., Perkovic, V., Cass, A., Turnbull, F., Gallagher, M., Zoungas, S., Heerspink, H., Chalmers, J., Zanchetti, A. (2010). Aspirin is beneficial in hypertensive patients with chronic kidney disease a post-hoc subgroup analysis of a randomized controlled trial. Journal of the American College of Cardiology, 56(12), 956-965. [More Information]
  • Lee, C., Stolk, R., Adler, A., Patel, A., Chalmers, J., Neal, B., Poulter, N., Harrap, S., Woodward, M., Marre, M., et al (2010). Association between alcohol consumption and diabetic retinopathy and visual acuity-the AdRem Study. Diabetic Medicine, 27(10), 1130-1137. [More Information]
  • Heeley, E., Peiris, D., Patel, A., Cass, A., Weekes, A., Morgan, C., Anderson, C., Chalmers, J. (2010). Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Medical Journal of Australia, 192(5), 254-259. [More Information]
  • Glasziou, P., Clarke, P., Alexander, J., Rajmokan, M., Beller, E., Woodward, M., Chalmers, J., Poulter, N., Patel, A. (2010). Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis. Medical Journal of Australia, 193(6), 320-324. [More Information]
  • Head, G., Mihailidou, A., Duggan, K., Beilin, L., Berry, N., Brown, M., Bune, A., Cowley, D., Chalmers, J., Howe, P., et al (2010). Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ: British Medical Journal, 340(c1104), 1-8. [More Information]
  • Lambers Heerspink, H., Ninomiya, T., Perkovic, V., Woodward, M., Zoungas, S., Cass, A., Cooper, M., Grobbee, D., Mancia, G., Mogensen, C., Neal, B., Chalmers, J. (2010). Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. European Heart Journal, doi:10.1093/eurheartj/ehq139, 1-9. [More Information]
  • Anderson, C., Huang, Y., Arima, H., Heeley, E., Skulina, C., Parsons, M., Peng, B., Li, Q., Su, S., Tao, Q., Chalmers, J., et al (2010). Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial(INTERACT). Stroke: a journal of cerebral circulation, 41(2), 307-312. [More Information]
  • Neal, B., Jun, M., Foote, C., Lv, J., Patel, A., Nicholls, S., Grobbee, D., Cass, A., Chalmers, J., Perkovic, V. (2010). Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. The Lancet, 375(9729), 1875-1884. [More Information]
  • Arima, H., Tzourio, C., Anderson, C., Woodward, M., Bousser, M., MacMahon, S., Neal, B., Chalmers, J. (2010). Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy. The PROGRESS Trial. Stroke: a journal of cerebral circulation, 41(2), 394-396. [More Information]
  • Ninomiya, T., Zoungas, S., Neal, B., Woodward, M., Patel, A., Perkovic, V., Cass, A., Cooper, M., Grobbee, D., Hamet, P., Rodgers, A., MacMahon, S., Chalmers, J., et al (2010). Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. Journal of Hypertension, 28(6), 1141-1149. [More Information]
  • Batty, G., Li, Q., Czernichow, S., Neal, B., Zoungas, S., Huxley, R., Patel, A., de Galan, B., Woodward, M., Hamet, P., Chalmers, J., et al (2010). Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) Trial. Journal of the American College of Cardiology, 56(23), 1908-1913. [More Information]
  • Patel, A., Neal, B., Chalmers, J. (2010). Event rates in trials of patients with type 2 diabetes. JAMA, 303(8), 732. [More Information]
  • Clarke, P., Glasziou, P., Patel, A., Chalmers, J., Woodward, M., Harrap, S., Salomon, J. (2010). Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Medicine, 7(2), e1000236-1-e1000236-10. [More Information]
  • Brugts, J., Isaacs, A., Boersma, E., van Duijn, C., Uitterlinden, A., Remme, W., Bertrand, M., Ninomiya, T., Ceconi, C., Chalmers, J., MacMahon, S., et al (2010). Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. European Heart Journal, 31(15), 1854-1864. [More Information]
  • Czernichow, S., Ninomiya, T., Huxley, R., Kengne, A., Batty, G., Grobbee, D., Woodward, M., Neal, B., Chalmers, J. (2010). Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial. Hypertension, 55(5), 1193-1198. [More Information]
  • Chalmers, J., Arima, H. (2010). Importance of Blood Pressure Lowering in Type 2 Diabetes: Focus on ADVANCE. Journal of Cardiovascular Pharmacology, 55(4), 340-347. [More Information]
  • Chalmers, J., Harrap, S., Narkiewicz, K., Poulter, N., Redon, J., Zanchetti, A., Mancia, G. (2010). Issues in the development of new combinations of blood pressure lowering drugs. Journal of Hypertension, 28(12), 2494-2496.
  • Arima, H., Anderson, C., Wang, J., Huang, Y., Heeley, E., Neal, B., Woodward, M., Skulina, C., Parsons, M., Peng, B., Chalmers, J., et al (2010). Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage. Hypertension, 56, 852-858. [More Information]
  • Li, Q., Chalmers, J., Czernichow, S., Neal, B., Taylor, B., Zoungas, S., Poulter, N., Woodward, M., Patel, A., de Galan, B., et al (2010). Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Diabetologia: clinical and experimental diabetes and metabolism, 53(11), 2320-2327. [More Information]
  • Arima, H., Anderson, C., Omae, T., Liu, L., Tzourio, C., Woodward, M., MacMahon, S., Neal, B., Rodgers, A., Chalmers, J. (2010). Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. Journal of Hypertension, 28(2), 395-400. [More Information]
  • Zoungas, S., Patel, A., Chalmers, J., de Galan, B., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Kengne, A., et al (2010). Severe hypoglycemia and risks of vascular events and death. New England Journal of Medicine, 363(15), 1410-1418. [More Information]
  • Zoungas, S., Chalmers, J., Kengne, A., Pillai, A., Billot, L., de Galan, B., Marre, M., Neal, B., Harrap, S., Poulter, N., Patel, A. (2010). The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial. Diabetes Research and Clinical Practice, 89(2), 126-133. [More Information]
  • Kengne, A., Patel, A., Colagiuri, S., Heller, S., Hamet, P., Marre, M., Pan, C., Zoungas, S., Grobbee, D., Neal, B., Chalmers, J., Woodward, M. (2010). The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia: clinical and experimental diabetes and metabolism, 53(5), 821-831. [More Information]
  • Delcourt, C., Huang, Y., Wang, J., Heeley, E., Lindley, R., Stapf, C., Tzourio, C., Arima, H., Parsons, M., Sun, J., Neal, B., Chalmers, J., Anderson, C. (2010). The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). International Journal of Stroke, 5(2), 110-116. [More Information]
  • Patel, A., Chalmers, J., MacMahon, S., Neal, B. (2009). ADVANCE: Blood Pressure Lowering in Diabetes (Letter to the Editor). Journal of Clinical Hypertension, 11(2), 108-108. [More Information]
  • Ninomiya, T., Perkovic, V., de Galan, B., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., Woodward, M., MacMahon, S., Chalmers, J., et al (2009). Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes. Journal of the American Society of Nephrology, 20(8), 1813-1821. [More Information]
  • Tavakoli, M., Pumford, N., Woodward, M., Doney, A., Chalmers, J., MacMahon, S., MacWalter, R. (2009). An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. The European Journal of Health Economics, 10, 111-119. [More Information]
  • Kengne, A., Czernichow, S., Huxley, R., Grobbee, D., Woodward, M., Neal, B., Zoungas, S., Cooper, M., Glasziou, P., Hamat, P., Chalmers, J., et al (2009). Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE. Hypertension, 54(2), 399-404. [More Information]
  • Zoungas, S., Chalmers, J., Patel, A. (2009). Cardiovascular Risk in Type 2 Diabetes - Reflecting on the ADVANCE Study. European Endocrinology, 5(1), 42-46.
  • Zoungas, S., Chalmers, J., Patel, A. (2009). Cardiovascular risk in Type 2 diabetes - reflecting on the ADVANCE study. U S Endocrinology, 5(1), 95-99.
  • Zoungas, S., Chalmers, J., Patel, A. (2009). Cardiovascular Risk in Type 2 Diabetes?Reflecting on the ADVANCE Study. U S Endocrinology, 5(1), 95-99.
  • de Galan, B., Zoungas, S., Chalmers, J., Anderson, C., Dufouil, C., Pillai, A., Cooper, M., Grobbee, D., Hackett, M., Hamet, P., MacMahon, S., Neal, B., Patel, A., Woodward, M., et al (2009). Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia: clinical and experimental diabetes and metabolism, 52(11), 2328-2336. [More Information]
  • Ninomiya, T., Donnan, G., Anderson, N., Bladin, C., Chambers, B., Gordon, G., Sharpe, N., Chalmers, J., Woodward, M., Neal, B. (2009). Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). Stroke: a journal of cerebral circulation, 40(6), 2111-2115. [More Information]
  • Czernichow, S., Lee, C., Barzi, F., Greenfield, J., Baur, L., Chalmers, J., Woodward, M., Huxley, R. (2009). Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials. Obesity Reviews, Online, 1-9. [More Information]
  • Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., Marre, M., Cooper, M., Glasziou, P., Grobbee, D., Joshi, R., et al (2009). Intensive blood glucose control on vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358(24), 2560-2572. [More Information]
  • Turnbull, F., Abraira, C., Anderson, R., Byington, R., Chalmers, J., Duckworth, W., Evans, G., Gerstein, H., Holman, R., Moritz, T., Neal, B., Ninomiya, T., Patel, A., Woodward, M., et al (2009). Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia: clinical and experimental diabetes and metabolism, 52(11), 2288-2298. [More Information]
  • de Galan, B., Perkovic, V., Ninomiya, T., Pillai, A., Patel, A., Cass, A., Neal, B., Poulter, N., Harrap, S., Mogensen, C., Woodward, M., MacMahon, S., Chalmers, J., et al (2009). Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes. Journal of the American Society of Nephrology, 20(4), 883-892. [More Information]
  • Chalmers, J., Arima, H. (2009). Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials. Polskie Archiwum Medycyny Wewnetrznej, 119(6), 373-380. [More Information]
  • Ninomiya, T., Perkovic, V., Verdon, C., Barzi, F., Cass, A., Gallagher, M., Jardine, M., Anderson, C., Chalmers, J., Craig, J., Huxley, R. (2009). Proteinuria and Stroke: A Meta-analysis of Cohort Studies. American Journal of Kidney Diseases, 53(3), 417-425. [More Information]
  • Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., Patel, A., et al (2009). Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. European Heart Journal, 30, 1128-1135. [More Information]
  • Joshi, R., de Galan, B., Chalmers, J., Perkovic, V., Patel, A. (2009). Routine blood pressure lowering and intense glucose control in patients with type 2 diabetes: results from the ADVANCE trial. Expert Review of Endocrinology and Metabolism, 4(2), 111-118.
  • Dufouil, C., Godin, O., Chalmers, J., Coskun, O., MacMahon, S., Tzourio-Mazoyer, N., Bousser, M., Anderson, C., Mazoyer, B., Tzourio, C. (2009). Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke: a journal of cerebral circulation, 40(6), 2219-2221. [More Information]
  • Arima, H., Wang, J., Huang, Y., Heeley, E., Skulina, C., Parsons, M., Peng, B., Li, Q., Su, S., Tao, Q., Chalmers, J., Anderson, C., et al (2009). Significance of perihematomal edema in acute intracerebral hemorrhage: The INTERACT trial. Neurology, 73(23), 1963-1968. [More Information]
  • Zoungas, S., de Galan, B., Ninomiya, T., Grobbee, D., Hamet, P., Heller, S., MacMahon, S., Marre, M., Neal, B., Patel, A., Woodward, M., Chalmers, J. (2009). The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care, 32(11), 2068-2074. [More Information]
  • Brugts, J., Ninomiya, T., Boersma, E., Remme, W., Bertrand, M., Ferrari, R., Fox, K., MacMahon, S., Chalmers, J., Simoons, M. (2009). The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. European Heart Journal, 30(11), 1385-1394. [More Information]
  • Chalmers, J., Joshi, R., Patel, A. (2008). Advances in reducing the burden of ascular disease in type 2 diabetes. Clinical and Experimental Pharmacology and Physiology, 35, 434-437. [More Information]
  • Chockalingham, A., Chalmers, J., Whitworth, J., Erdine, S., Mancia, G., Mendis, S., Heagerty, A. (2008). Antalya statement of the International Society of Hypertension on the prevention of blood pressure-related diseases. Journal of Hypertension, 26, 2255-2258. [More Information]
  • Tzourio, C., Arima, H., Harrap, S., Anderson, C., Godin, O., Woodward, M., Neal, B., Bousser, M., Chalmers, J., Cambien, F., MacMahon, S. (2008). APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology, 70(16 (Part 1-2)), 1322-1328. [More Information]
  • Welsh, P., Lowe, G., Chalmers, J., Campbell, D., Rumley, A., Neal, B., MacMahon, S., Woodward, M. (2008). Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke. Stroke: a journal of cerebral circulation, 39, 2226-2230. [More Information]
  • Chalmers, J., Joshi, R., Kengne, A., MacMahon, S. (2008). Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE. Journal of Hypertension, 26(suppl 2), S11-S15. [More Information]
  • Turnbull, F., Woodward, M., Neal, B., Barzi, F., Ninomiya, T., Chalmers, J., Perkovic, V., Li, N., MacMahon, S. (2008). Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. European Heart Journal, 29(21), 2669-2680. [More Information]
  • Turnbull, F., Neal, B., Ninomiya, T., Algert, C., Arima, H., Barzi, F., Bulpitt, C., Chalmers, J., Fagard, R., Gleason, A., Heritier, S., Perkovic, V., Woodward, M., MacMahon, S., et al (2008). Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ: British Medical Journal, 336(6753), 1121-1123. [More Information]
  • Chalmers, J., Joshi, R., Kengne, A., Ninomiya, T., Bi, Y., Bompoint, S., Billot, L., Patel, A. (2008). Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence. Journal of Hypertension, 26(Suppl 3), S21-S27. [More Information]
  • Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., Marre, M., Cooper, M., Glasziou, P., Grobbee, D., Joshi, R., et al (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358(24), 2560-2572. [More Information]
  • Anderson, C., Huang, Y., Wang, J., Arima, H., Neal, B., Peng, B., Heeley, E., Skulina, C., Parsons, M., Jong, S., Heritier, S., Chalmers, J., et al (2008). Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurology, 7(5), 391-399. [More Information]
  • Patel, A., MacMahon, S., Chalmers, J. (2008). Intensive glucose control in type 2 diabetes - the author's reply. New England Journal of Medicine, 359, 1519-21.
  • Chalmers, J., Zhang, J. (2008). Introduction: Advances in the prevention of cardiovascular disease in patients with diabetes. Journal of Hypertension, 26, S1-2. [More Information]
  • Ninomiya, T., Perkovic, V., Gallagher, M., Jardine, M., Cass, A., Arima, H., Anderson, C., Neal, B., Woodward, M., Omae, T., MacMahon, S., Chalmers, J. (2008). Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial. Kidney International, 73(8), 963-970. [More Information]
  • Wu, Y., Huxley, R., Li, L., Anna, V., Xie, G., Yao, C., Woodward, M., Li, X., Chalmers, J., Gao, R., et al (2008). Prevalence, Awareness, Treatment, and Control of Hypertension in China: Data from the China National Nutrition and Health Survey 2002. Circulation, 118(25), 2679-2686. [More Information]
  • Patel, A., MacMahon, S., Billot, L., Chalmers, J. (2008). The ADVANCE Trial - the author's reply. The Lancet, 371(9606), 25-26.
  • Perkovic, V., Verdon, C., Ninomiya, T., Barzi, F., Cass, A., Patel, A., Jardine, M., Gallagher, M., Turnbull, F., Chalmers, J., Craig, J., Huxley, R. (2008). The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Medicine, 5(10), 1486-1495. [More Information]
  • Chalmers, J., Cooper, M. (2008). UKPDS and the legacy effect. The New England Journal of Medicine, 359(15), 1618-20. [More Information]
  • Turnbull, F., Neal, B., Pfeffer, M., Kostis, J., Algert, C., Woodward, M., Chalmers, J., Zanchetti, A., MacMahon, S. (2007). Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. Journal of Hypertension, 25(5), 951-958. [More Information]
  • Perkovic, V., Ninomiya, T., Arima, H., Jardine, M., Cass, A., Neal, B., MacMahon, S., Chalmers, J. (2007). Chronic Kidney Disease, Cardiovascular Events, and The Effects Of Perindopril-Based Blood Pressure Lowering: Data From The PROGRESS Study. Journal of the American Society of Nephrology, 18(10), 2766-2772. [More Information]
  • Patel, A., MacMahon, S., Chalmers, J., Neal, B., Woodward, M., Billot, L., Harrap, S., Poulter, N., Marre, M., Cooper, M., Glasziou, P., Grobbee, D., Rodgers, A., et al (2007). Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet, 370(September 8), 829-840.
  • Chalmers, J., Zhang, J. (2007). Introduction. Journal of Hypertension, 25, S1-2. [More Information]
  • Campbell, D., Neal, B., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S., Woodward, M. (2007). Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14(3), 413-418. [More Information]
  • Chalmers, J., Kengne, A., Joshi, R., Perkovic, V., Patel, A. (2007). New insights from ADVANCE. Journal of Hypertension, 25(Suppl. 1), S23-S30. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2007). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in subjects with cerebrovascular disease. Journal of Hypertension, 25(3), 699-705. [More Information]
  • Chalmers, J., Perkovic, V., Joshi, R., Patel, A. (2006). ADVANCE: breaking new ground in type 2 diabetes. Journal of Hypertension, 24(Supplement 5), S22-S28. [More Information]
  • Perkovic, V., Joshi, R., Patel, A., Bompoint, S., Chalmers, J., Neal, B., MacMahon, S., Glasziou, P., Woodward, M., Cooper, M., et al (2006). ADVANCE: Lessons from the run-in phase of a large study in type 2 diabetes. Blood Pressure, 15(6), 340-346. [More Information]
  • Chalmers, J. (2006). Blood pressure and stroke: a continuing debate. Journal of Hypertension, 24(7), 1249-51. [More Information]
  • Gallagher, M., Perkovic, V., Chalmers, J. (2006). Diuretics: A modern day treatment option? (Review Article). Nephrology, 11(5), 419-427. [More Information]
  • Arima, H., Chalmers, J., Woodward, M., Anderson, C., Rodgers, A., Davis, S., MacMahon, S., Neal, B., PROGRESS, C. (2006). Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. Journal of Hypertension, 24(6), 1201-1208. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S. (2006). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease. European Heart Journal, 27(Suppl 1), 781.
  • Arima, H., Tzourio, C., Butcher, K., Anderson, C., Bousser, M., Lees, K., Reid, J., Omae, T., Woodward, M., MacMahon, S., Chalmers, J. (2006). Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial. Stroke: a journal of cerebral circulation, 37(6), 1497-1502. [More Information]
  • Arima, H., Chalmers, J. (2006). Secondary prevention of stroke by blood pressure-lowering treatment. Current Hypertension Reports, 8(4), 317-323. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2006). Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. JAMA Neurology, 63(1), 60-65. [More Information]
  • Chalmers, J., MacMahon, S., Colman, S., Heller, S., Neal, B., Pan, C., Patel, A., Woodward, M., Cooper, M., Adams, M., Fulcher, G., Mitchell, P., Pollock, C., Watson, J., et al (2005). ADVANCE - Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline. Diabetic Medicine, 22(7), 882-888.
  • Patel, A., Chalmers, J., Poulter, N. (2005). ADVANCE: action in diabetes and vascular disease. Journal of Human Hypertension, 19(Suppl 1), S27-S32. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Neal, B., Patel, A., MacMahon, S. (2005). Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons. European Heart Journal, 26(Suppl 1), 257.
  • Woodward, M., Lowe, G., Campbell, D., Colman, S., Rumley, A., Chalmers, J., Neal, B., Patel, A., Jenkins, A., Kemp, B., MacMahon, S. (2005). Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke. Stroke: a journal of cerebral circulation, 36(10), 2143-2147. [More Information]
  • Chalmers, J. (2005). Blood pressure in acute stroke: in search of evidence. Journal of Hypertension, 23(2), 277-8. [More Information]
  • Dufouil, C., Chalmers, J., Coskun, O., Besancon, V., Bousser, M., Guillon, P., MacMahon, S., Mazoyer, B., Neal, B., Woodward, M., Tzourio, C., et al (2005). Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation, 112(11), 1644-1650. [More Information]
  • Turnbull, F., Neal, B., Algert, C., Chalmers, J., Chapman, N., Cutler, J., Woodward, M., MacMahon, S. (2005). Effects of Different Blood Pressure-Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus: Results of Prospectively Designed Overviews of Randomized Trials. Archives of Internal Medicine, 165(12), 1410-1419. [More Information]
  • Arima, H., Hart, R., Colman, S., Chalmers, J., Anderson, C., Rodgers, A., Woodward, M., MacMahon, S., Neal, B. (2005). Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack. Stroke: a journal of cerebral circulation, 36(10), 2164-2169. [More Information]
  • Patel, A., Woodward, M., Campbell, D., Sullivan, D., Colman, S., Chalmers, J., Neal, B., MacMahon, S. (2005). Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. European Heart Journal, 26(18), 1910-1915. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease. Hypertension, 45(1), 69-74.
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation, 112(1), 110-116. [More Information]
  • MacMahon, S., Neal, B., Rodgers, A., Chalmers, J. (2004). Commentary: The PROGRESS trial three years later: time for more action, less distraction. BMJ: British Medical Journal, 329(7472), 970-971.
  • Chalmers, J. (2004). Comparison Of Various Blood Pressure Lowering Treatments on the Primary Prevention of Cardiovascular Outcomes in Recent Randomised Clinical Trials. Clinical and Experimental Hypertension, 26(7-8), 709-719.
  • Chapman, N., Huxley, R., Anderson, C., Bousser, M., Chalmers, J., Colman, S., Davis, S., Donnan, G., MacMahon, S., Neal, B., Woodward, M., et al (2004). Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial. Stroke: a journal of cerebral circulation, 35(1), 116-121.
  • Ohkubo, T., Chapman, N., Neal, B., Woodward, M., Omae, T., Chalmers, J., Anderson, C. (2004). Effects of an Angiotensin-converting Enzyme Inhibitor-based Regimen on Pneumonia Risk. American Journal of Respiratory and Critical Care Medicine, 169(9), 1041-1045.
  • Hasegawa, Y., Yamaguchi, T., Omae, T., Woodward, M., Chalmers, J. (2004). Effects of Perindopril-Based Blood Pressure Lowering and of Patient Characteristics on the Progression of Silent Brain Infarct: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. Hypertension Research, 27(3), 147-156.
  • Berthet, K., Neal, B., MacMahon, S., Bousser, M., Colman, S., Woodward, M., Chalmers, J. (2004). Lacunar stroke in PROGRESS study. European Journal of Neurology, 11(Suppl 2), 29.
  • Chalmers, J. (2004). Nouvelles Strategies Pour Le Controle De L'Hypertension: Preuves Supplementaries En Faveur Des Associations Faiblement Dosees. (New Strategies For Hypertension Control : More Evidence For Low-Dose Combination Therapy). American Journal of Cardiovascular Drugs, 4(Supplement 1), 37-42.
  • Rodgers, A., Chapman, N., Woodward, M., Liu, L., Colman, S., Lee, A., Chalmers, J., MacMahon, S., Anderson, C. (2004). Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Journal of Hypertension, 22(3), 653-659.
  • Berthet, K., Neal, B., Chalmers, J., MacMahon, S., Bousser, M., Colman, S., Woodward, M., Anderson, C. (2004). Reductions in the Risks of Recurrent Stroke in Patients With and Without Diabetes: The PROGRESS Trial. Blood Pressure, 13(1), 7-13.
  • MacMahon, S., Chalmers, J. (2003). Blood pressure lowering and ACE inhibition for the avoidance of cardiac and cerebral events. European Heart Journal, 24(5), 391-393.
  • Patel, A., Chalmers, J., Chaturvedi, V., Currie, R., Monaghan, H., Neal, B., MacMahon, S. (2003). Diabetes and vascular disease: A new international trial. Asian Cardiovascular and Thoracic Annals, 11(2), 180-184.
  • Patel, A., Chalmers, J., Chaturvedi, V., Currie, R., Monaghan, H., Neal, B. (2003). Diabetes and vascular disease: a new international trial. Asian Cardiovascular and Thoracic Annals, 11(2), 180-184.
  • Chaturvedi, V., Patel, A., Chalmers, J., Chapman, N., Hansson, L., MacMahon, S., Mancia, G., Neal, B., Reid, J., Sharpe, N., Woodward, M., Anderson, C., et al (2003). Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. European Heart Journal, 24(5), 475-484.
  • Fransen, M., Anderson, C., Chalmers, J., Chapman, N., Davis, S., MacMahon, S., Neal, B., Sega, R., Terent, A., Tzourio, C., Woodward, M. (2003). Effects of a Perindopril-Based Blood Pressure-Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular Disease: A Randomized Controlled Trial. Stroke: a journal of cerebral circulation, 34(10), 2333-2338.
  • Tzourio, C., Anderson, C., Chapman, N., Woodward, M., Neal, B., MacMahon, S., Chalmers, J., Lindley, R. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163(9), 1069-1075. [More Information]
  • Turnbull, F., Neal, B., Algert, C., Chalmers, J., Woodward, M., MacMahon, S. (2003). Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. The Lancet, 362(9395), 1527-1535.
  • Chalmers, J. (2003). Etude ADVANCE: objectifs, protocole et etat actuel. Drugs, 63(Special Issue 1), 39-44.
  • Chalmers, J., Todd, A., Chapman, N., Beilin, L., Davis, S., Donnan, G., Frommer, M., Huxley, R., Lenfant, C., MacMahon, S., et al (2003). International Society of hypertension (ISH): Statement on blood pressure lowering and stroke prevention. Journal of Hypertension, 21(4), 651-663.
  • Bath, P., Chalmers, J., Powers, W., Lawrie, B., Davis, S., Lenfant, C., Mancia, G., Neal, B., Whitworth, J., Zanchetti, A. (2003). International society of hypertension (ISH): Statement on the management of blood pressure in acute stroke. Journal of Hypertension, 21(4), 665-672.
  • Chalmers, J., Arnolda, L. (2003). Lowering blood pressure in 2003. Medical Journal of Australia, 179(6), 306-312.
  • Chalmers, J., MacMahon, S. (2003). Perindopril Protection Against Recurrent Stroke Study (PROGRESS) : Interpretation and implementation. Journal of Hypertension, 21(Suppl 5), S9-S14.
  • Harrap, S., Tzourio, C., Cambien, F., Poirier, O., Raoux, S., Chalmers, J., Chapman, N., Colman, S., Leguennec, S., MacMahon, S., Neal, B., Ohkubo, T., Woodward, M., Anderson, C. (2003). The ACE Gene I/D Polymorphism Is Not Associated With the Blood Pressure and Cardiovascular Benefits of ACE Inhibition. Hypertension, 42(3), 297-303.
  • Fransen, M., Anderson, C., Chalmers, J., Chapman, N., Davis, S., MacMahon, S., Neal, B., Sega, R., Terent, A., Tzourio, C., Woodward, M. (2003). The effects of a perindopril-based blood pressure lowering regimen on disability and dependency in 6,105 patients with cerebrovascular disease. A randomised controlled trial. Stroke: a journal of cerebral circulation, (DOI: 10.1161/01.STR.0000091397.81767.40), 2333-2338.
  • Chapman, N., Chalmers, J. (2003). The prevention of secondary stroke, cardiac outcomes and cognitive decline in patients with cerebrovascular disease: The PROGRESS Trial. Seminars In Cerebrovascualr Diseases and Stroke, 3(3), 171-180.
  • Chalmers, J. (2003). Trials on blood pressure-lowering and secondary stroke prevention. The American Journal of Cardiology, 91(10A), 3G-8G.
  • Chalmers, J. (2002). Enhancing risk stratification in hypertensive subjects: how far should we go in routine screening for target organ damage? Journal of Hypertension, , 1255-1257.
  • Freedman, B., Brieger, D., Celermajer, D., Chalmers, J., Tofler, G., Campbell, T., Feneley, M., Marwick, T., Muller, D., Tonkin, A. (2002). Global cardiology comes to Australia: 14th World Congress of Cardiology, Sydney, 5-9 May 2002. Medical Journal of Australia, , 473-475.
  • Chalmers, J. (2002). The ABCD of anti-hypertensive therapy? Journal of Hypertension, , 1-2.
  • Chalmers, J. (2002). Treating Hypertension or Lowering Blood Pressure? Extending the Concept. Blood Pressure, , 68-70.
  • Chalmers, J., Whitworth, J. (2001). A half-century of Australian health and medical research. Medical Journal of Australia, 174, 29-32.
  • Neal, B., Chapman, J., Chalmers, J., MacMahon, S., Girgis, S., Patel, A. (2001). Blood pressure and the vascular complications of diabetes. Medicographia, 23(3), 214-219.
  • Chalmers, J., Neal, B., Chapman, J., MacMahon, S., Patel, A., Girgis, S. (2001). Blood pressure lowering in diabetes: a brief review of the current evidence and description of a new trial. Clinical and Experimental Pharmacology and Physiology, 28, 1108-1111.
  • Goodchild, A., Sun, Q., Chalmers, J., Pilowsky, P., Llewellyn-Smith, I., Cunningham, A. (2001). Calbindin-Ummunoreactive neurons in the reticular formation of the rat brainstem: catecholamine content and spinal projections. The Journal of Comparative Neurology, 424, 547-562.
  • Chalmers, J., Chapman, J. (2001). Challenges for the prevention of primary and secondary stroke: the importance of lowering blood pressure and total cardiovascular risk. Blood Pressure, 10, 344-351.
  • Goodchild, A., Chalmers, J., Pilowsky, P., Phillips, J., Dubey, R., Sesiashvili, E., Takeda, M., Lipski,, J. (2001). Differential expression of catecholamine biosynthetic enzymes in the rat ventrolateral medulla. The Journal of Comparative Neurology, 431, 20-34.
  • Chalmers, J. (2001). Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us. American Journal of Hypertension, 14.
  • Chalmers, J., Chapman, J. (2001). Progress in reducing the burden of stroke. Clinical and Experimental Pharmacology and Physiology, 28, 1091-1095.
  • MacMahon, S., Neal, B., Woodward, M., Chalmers, J., Tzourio, C., Rodgers, A., Cutler, J., Ohkubo,, T., Lindley, R., Anderson, C. (2001). Randomised trail of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. The Lancet, 358, 1033-1041.
  • Chalmers, J., MacMahon, S., Neal, B., Girgis, S., Patel, A. (2001). Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Journal of Hypertension, 19 (suppl 4).
  • MacMahon, S., Rodgers, A., Neal, B., Woodward, M., Chalmers, J. (2001). REPLY: The lowering of blood pressure after stroke. The Lancet, 358(9297), 1994-1995.
  • Chalmers, J., MacMahon, S., Neal, B., Ferrannini, E., Girgis, S., Patel, A. (2001). Study rationale and design of ADVANCE: Action in diabetes and vascular disease - preterax and diamicron MR controlled evaluation. Diabetologia: clinical and experimental diabetes and metabolism, 44, 1118-1120.

Conferences

  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2008). Can NT-proBNP Monitoring Help Prevent Cardiovascular Disease? 13th World Congress on Heart Disease, Italy: Medimond International Proceedings.

2014

  • Fischer, U., Cooney, M., Bull, L., Silver, L., Chalmers, J., Anderson, C., Mehta, Z., Rothwell, P. (2014). Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. Lancet Neurology, 13(4), 374-384. [More Information]
  • Zheng, D., Arima, H., Heeley, E., Karpin, A., Heller, G., Yang, J., Chalmers, J., Anderson, C. (2014). Ambient Temperature and Severity of Intracerebral Haemorrhage: The INTERACT1 Study. Neuroepidemiology, 42(3), 169-173. [More Information]
  • Manning, L., Hirakawa, Y., Arima, H., Wang, X., Chalmers, J., Wang, J., Lindley, R., Heeley, E., Delcourt, C., Neal, B., Woodward, M., Anderson, C., et al (2014). Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurology, 13(4), 364-373. [More Information]
  • Lowe, G., Woodward, M., Hillis, G., Rumley, A., Li, Q., Harrap, S., Marre, M., Hamet, P., Patel, A., Poulter, N., Chalmers, J. (2014). Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study. Diabetes, 63(3), 1115-1123. [More Information]
  • Weber, M., Schiffrin, E., White, W., Mann, S., Lindholm, L., Kenerson, J., Flack, J., Carter, B., Materson, B., Ram, C., Chalmers, J., et al (2014). Clinical Practice Guidelines for the Management of Hypertension in the Community. A Statement by the American Society of Hypertension and the International Society of Hypertension. Journal of Hypertension, 32(1), 3-15. [More Information]
  • Chalmers, J., Arima, H., Woodward, M., Mancia, G., Poulter, N., Hirakawa, Y., Zoungas, S., Patel, A., Williams, B., Harrap, S. (2014). Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial. Hypertension, 63(2), 259-264. [More Information]
  • Van Dieren, S., Kengne, A., Chalmers, J., Beulens, J., Davis, T., Fulcher, G., Heller, S., Patel, A., Colagiuri, S., Hamet, P., Neal, B., Woodward, M., Zoungas, S., et al (2014). Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial. Diabetes, Obesity and Metabolism, 16(5), 426-432. [More Information]
  • Land, M., Jeffery, P., Webster, J., Crino, M., Chalmers, J., Woodward, M., Nowson,, C., Smith, W., Flood, V., Neal, B. (2014). Protocol for the implementation and evaluation of a community-based intervention seeking to reduce dietary salt intake in Lithgow, Australia. BMC Public Health, 14(1), 1-7. [More Information]
  • Ding, M., Rogers, K., Macniven, R., Kamalesh, V., Kritharides, L., Chalmers, J., Bauman, A. (2014). Revisiting Lifestyle Risk Index Assessment in a Large Australian Sample: Are Sedentary Behavior and Sleep Correlated with Health Outcomes. Preventive Medicine, 60, 102-106. [More Information]
  • Land, M., Webster, J., Christofolou, A., Praveen, D., Jeffery, P., Chalmers, J., Smith, W., Woodward, M., Barzi, F., Nowson,, C., Neal, B., et al (2014). Salt intake assessed by 24 h urinary sodium excretion in a random and opportunistic sample in Australia. BMJ Open, 4(2), 1-7. [More Information]
  • Chen, G., Arima, H., Wu, G., Heeley, E., Delcourt, C., Zhang, P., Rabinstein, A., Robinson, T., Stapf, C., Huang, Y., Song, L., Yang, J., Wang, X., Li, Q., Chen, X., Chalmers, J., Anderson, C. (2014). Subarachnoid Extension of Intracerebral Hemorrhage and 90-Day Outcomes in INTERACT2. Stroke, 45(1), 258-260. [More Information]
  • Land, M., Webster, J., Christofolou, A., Johnson, C., Trevena, H., Hodgins, F., Chalmers, J., Woodward, M., Barzi, F., Smith, W., Flood, V., Neal, B., et al (2014). The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion. The International Journal of Behavioral Nutrition and Physical Activity, 11(1), 1-8. [More Information]
  • Hillis, G., Welsh, P., Chalmers, J., Perkovic, V., Chow, C., Li, Q., Jun, M., Neal, B., Zoungas, S., Poulter, N., Woodward, M., et al (2014). The relative and combined ability of high sensitivity cardiac troponin T and N-terminal pro-BNP to predict cardiovascular events and death in patients with type 2 diabetes mellitus. Diabetes Care, 37(1), 295-303. [More Information]

2013

  • Rist, P., Chalmers, J., Arima, H., Anderson, C., MacMahon, S., Woodward, M., Kurth, T., Tzourio, C. (2013). Baseline Cognitive Function, Recurrent Stroke, and Risk of Dementia in Patients With Stroke. Stroke, 44(7), 1790-1795. [More Information]
  • Ninomiya, T., Perkovic, V., Turnbull, F., Neal, B., Barzi, F., Cass, A., Baigent, C., Chalmers, J., Li, N., Woodward, M., MacMahon, S. (2013). Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ, 347(7929), 1-15. [More Information]
  • Wong, M., Perkovic, V., Woodward, M., Chalmers, J., Li, Q., Hillis, G., Azari, E., Jun, M., Poulter, N., Hamet, P., Neal, B., Pollock, C., et al (2013). Circulating bone morphogenetic protein-7 and transforming growth factor-(beta)1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney International, 83(2), 278-284. [More Information]
  • Chalmers, J. (2013). Current issues with dual inhibition of the renin-angiotensin system. Journal of Hypertension, 31(2), 261-262. [More Information]
  • Hata, J., Arima, H., Zoungas, S., Fulcher, G., Pollock, C., Adams, M., Watson, J., Joshi, R., Kengne, A., Ninomiya, T., Anderson, C., Woodward, M., Patel, A., MacMahon, S., Chalmers, J., Neal, B., et al (2013). Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial. PLoS One, 8(2), 1-7. [More Information]
  • Hata, J., Arima, H., Rothwell, P., Woodward, M., Zoungas, S., Anderson, C., Patel, A., Neal, B., Glasziou, P., Hamet, P., MacMahon, S., Chalmers, J., et al (2013). Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The ADVANCE trial. Circulation, 128(12), 1325-1334. [More Information]
  • Banks, E., Joshy, G., Abhayaratna, W., Kritharides, L., MacDonald, P., Korda, R., Chalmers, J. (2013). Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort Study. PLoS Medicine, 10(1), 1-13. [More Information]
  • Chalmers, J., Arima, H., Harrap, S., Touyz, R., Park, J. (2013). Global survey of current practice in management of hypertension as reported by societies affiliated with the international society of hypertension. Journal of Hypertension, 31(5), 1043-1048. [More Information]
  • Perkovic, V., Heerspink, H., Chalmers, J., Woodward, M., Jun, M., Li, Q., MacMahon, S., Cooper, M., Hamet, P., Marre, M., Cass, A., Patel, A., Zoungas, S., et al (2013). Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney International, 83(3), 517-523. [More Information]
  • Batty, G., Li, Q., Huxley, R., Zoungas, S., Taylor, B., Neal, B., de Galan, B., Woodward, M., Harrap, S., Colagiuri, S., Patel, A., Chalmers, J. (2013). Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. European Psychiatry, 28(1), 49-52. [More Information]
  • Chalmers, J., Angus, J., Graham, R., Carmody, J., Dampney, R., Jennings, G., Korner, N. (2013). Paul Ivan Korner 1925-2012. Historical Records of Australian Science, 24(2), 251-282. [More Information]
  • Anderson, C., Heeley, E., Huang, Y., Wang, J., Stapf, C., Delcourt, C., Lindley, R., Robinson, T., Lavados, P., Neal, B., Hata, J., Arima, H., Heritier, S., Li, Q., Woodward, M., Simes, R., Chalmers, J., et al (2013). Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage. The New England Journal of Medicine, 368(25), 2355-2365. [More Information]
  • Anderson, C., Heeley, E., Heritier, S., Arima, H., Woodward, M., Lindley, R., Neal, B., Huang, Y., Wang, J., Parsons, M., Delcourt, C., Chalmers, J., et al (2013). Statistical analysis plan for the second INTEnsive blood pressure Reduction in Acute Cerebral hemorrhage Trial (INTERACT2): a large-scale investigation to solve longstanding controversy over the most appropriate management of elevated blood pressure in the hyperacute phase of intracerebral hemorrhage. International Journal of Stroke, 8(5), 327-328. [More Information]
  • Morton, J., Ng, M., Chalmers, J., Woodward, M., Mancia, G., Poulter, N., Marre, M., Cooper, M., Zoungas, S. (2013). The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? Cancer Epidemiology, Biomarkers and Prevention, 22(9), 1628-1633. [More Information]
  • Perkovic, V., Woodward, M., Zoungas, S., Chalmers, J. (2013). The authors reply Caution advised in interpreting nonsignificant results from ADVANCE post hoc analysis. Kidney International, 84(3), 622-622. [More Information]
  • Justin Zaman, M., Patel, A., Chalmers, J., Woodward, M., Clarke, P., Li, Q., Zoungas, S. (2013). The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes. Diabetic Medicine, 30(8), 918-925. [More Information]
  • Blomster, J., Chow, C., Zoungas, S., Woodward, M., Patel, A., Poulter, N., Marre, M., Harrap, S., Chalmers, J., Hillis, G. (2013). The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, 15(11), 1008-1012. [More Information]
  • Stefansdottir, G., Zoungas, S., Chalmers, J., Knol, M., Leufkens, H., Woodward, M., Patel, A., Grobbee, D., De Bruin, M. (2013). The Post Hoc Use of Randomised Controlled Trials to Explore Drug Associated Cancer Outcomes: Methodological Challenges. Current Drug Safety, 8(5), 371-378. [More Information]

2012

  • Zoungas, S., Chalmers, J., Li, Q., Woodward, M. (2012). ADVANCE and glycaemia thresholds: a need to clarify the statistical approach. Reply to Currie CJ [letter]. Diabetologia: clinical and experimental diabetes and metabolism, 55(8), 2300-2300. [More Information]
  • Zoungas, S., Chalmers, J., Ninomiya, T., Li, Q., Cooper, M., Colagiuri, S., Fulcher, G., de Galan, B., Harrap, S., Hamet, P., Patel, A., Neal, B., Woodward, M., et al (2012). Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia: clinical and experimental diabetes and metabolism, 55(3), 636-643. [More Information]
  • Fox, C., Matsushita, K., Woodward, M., Bilo, H., Chalmers, J., Heerspink, H., Lee, B., Perkins, R., Rossing, P., Sairenchi, T., et al (2012). Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. The Lancet, 380(9854), 1662-1673. [More Information]
  • Razavian, M., Heeley, E., Perkovic, V., Zoungas, S., Weekes, A., Patel, A., Anderson, C., Chalmers, J., Cass, A. (2012). Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrology, Dialysis, Transplantation, 27(4), 1396-1402. [More Information]
  • Chapman, N., Arima, H., Chalmers, J., Anderson, C. (2012). Cerebrovascular Disease in Hypertension. In Henry R Black and William J Elliott (Eds.), Hypertension: A Companion to Braunwald's Heart Disease, Second Edition, (pp. 303-312). Philadelphia: Elsevier.
  • Hata, J., Arima, H., Anderson, C., Chalmers, J. (2012). Cognitive Function and Dementia in Hypertension: Epidemiologic and Therapeutic Aspects. In Adel E. Berbari and Giuseppe Mancia (Eds.), Special Issues in Hypertension, (pp. 399-412). Milan, Italy: Springer.
  • Chalmers, J., Arima, H., Hata, J. (2012). Cost-effective reduction in stroke: lessons from the Japanese hypertension detection and control program. Journal of Hypertension, 30(9), 1706-1707. [More Information]
  • Heeley, E., Anderson, C., Patel, A., Cass, A., Peiris, D., Weekes, A., Chalmers, J. (2012). Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice. International Journal of Stroke, 7(8), 649-654. [More Information]
  • Arima, H., Huang, Y., Wang, J., Heeley, E., Delcourt, C., Parsons, M., Li, Q., Neal, B., Chalmers, J., Anderson, C. (2012). Earlier Blood Pressure-Lowering and Greater Attenuation of Hematoma Growth in Acute Intracerebral Hemorrhage: INTERACT Pilot Phase. Stroke, 43(8), 2236-2238. [More Information]
  • Van Dieren, S., Kengne, A., Chalmers, J., Beulens, J., Cooper, M., Grobbee, D., Harrap, S., Mancia, G., Neal, B., Patel, A., Woodward, M., Zoungas, S., et al (2012). Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. Diabetes Research and Clinical Practice, 98(1), 83-90. [More Information]
  • Arima, H., Anderson, C., Omae, T., Woodward, M., MacMahon, S., Mancia, G., Bousser, M., Tzourio, C., Rodgers, A., Neal, B., Chalmers, J. (2012). Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial. Stroke, 43(6), 1675-1677. [More Information]
  • Lv, J., Neal, B., Ehteshami, P., Ninomiya, T., Woodward, M., Rodgers, A., Wang, H., MacMahon, S., Turnbull, F., Hillis, G., Chalmers, J., Perkovic, V. (2012). Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Medicine, 9(8), 1-14. [More Information]
  • Salvi, E., Kutalik, Z., Glorioso, N., Benaglio, P., Frau, F., Kuznetsova, T., Arima, H., Hoggart, C., Tichet, J., Nikitin, Y., Chalmers, J., et al (2012). Genomewide Association Study Using a High-Density Single Nucleotide Polymorphism Array and Case-Control Design Identifies a Novel Essential Hypertension Susceptibility Locus in the Promoter Region of Endothelial NO Synthase. Hypertension, 59(2), 248-255. [More Information]
  • Zoungas, S., Chalmers, J. (2012). Glycemic control and outcomes in people with diabetes and CKD. Nature Reviews Nephrology, 8(3), 133-134. [More Information]
  • Delcourt, C., Huang, Y., Arima, H., Chalmers, J., Davis, S., Heeley, E., Wang, J., Parsons, M., Liu, G., Anderson, C. (2012). Hematoma growth and outcomes in intracerebral hemorrhage: The INTERACT1 study. Neurology, 79(4), 314-319. [More Information]
  • Knott, R., Cass, A., Heeley, E., Chalmers, J., Pieris, D., Clarke, P. (2012). How fair is Medicare? The income-related distribution of Medicare benefits with special focus on chronic care items. Medical Journal of Australia, 197(11/12), 1-5. [More Information]
  • Morton, J., Zoungas, S., Li, Q., Patel, A., Chalmers, J., Woodward, M., Celermajer, D., Beulens, J., Stolk, R., Glasziou, P., Ng, M. (2012). Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study. Diabetes Care, 35(11), 2201-2206. [More Information]
  • Chalmers, J. (2012). Making Good Use of Diastolic and Systolic Blood Pressures in the Management of Hypertension. Hypertension, 60(5), 1110-1111. [More Information]
  • Kengne, A., Sobngwi, E., Chalmers, J. (2012). Multiple risk factor interventions and inflammatory biomarkers in high risk individuals with type 2 diabetes. Diabetes Research and Clinical Practice, 95(3), 386-388. [More Information]
  • Jardine, M., Hata, J., Woodward, M., Perkovic, V., Ninomiya, T., Arima, H., Zoungas, S., Cass, A., Patel, A., Marre, M., Chalmers, J., et al (2012). Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes. American Journal of Kidney Diseases, 60(5), 770-778. [More Information]
  • Hillis, G., Woodward, M., Rodgers, A., Chow, C., Li, Q., Zoungas, S., Patel, A., Webster, R., Batty, G., Ninomiya, T., Chalmers, J., et al (2012). Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia: clinical and experimental diabetes and metabolism, 55(5), 1283-1290. [More Information]
  • Hillis, G., Hata, J., Woodward, M., Perkovic, V., Arima, H., Chow, C., Zoungas, S., Patel, A., Poulter, N., Mancia, G., Chalmers, J., et al (2012). Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus. Journal of the American Heart Association, 1(5), 1-11. [More Information]
  • Wong, G., Zoungas, S., Lo, S., Chalmers, J., Cass, A., Neal, B., Woodward, M., Perkovic, V., Glasziou, P., Williams, B., Howard, K., Chapman, J., Craig, J. (2012). The risk of cancer in people with diabetes and chronic kidney disease. Nephrology, Dialysis, Transplantation, 27(8), 3337-3344. [More Information]
  • Van Dieren, S., Czernichow, S., Chalmers, J., Kengne, A., de Galan, B., Poulter, N., Woodward, M., Beulens, J., Grobbee, D., van der Schouw, Y., Zoungas, S. (2012). Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial. Diabetes, Obesity and Metabolism, 14(5), 464-469. [More Information]

2011

  • Brugts, J., Isaacs, A., de Maat, M., Boersma, E., van Duijn, C., Akkerhuis, K., Uitterlinden, A., Witteman, J., Cambien, F., Ceconi, C., Ninomiya, T., Chalmers, J., MacMahon, S., et al (2011). A Pharmacogenetic Analysis of Determinants of Hypertension and Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Vascular Disease and Healthy Individuals. Journal of Hypertension, 29(3), 509-519. [More Information]
  • Salomon, J., Patel, A., Neal, B., Glasziou, P., Grobbee, D., Chalmers, J., Clarke, P. (2011). Comparability of Patient-reported Health Status: Multicountry Analysis of EQ-5D Responses in Patients With Type 2 Diabetes. Medical Care, 49(10), 962-969. [More Information]
  • Czernichow, S., Kengne, A., Huxley, R., Batty, G., de Galan, B., Grobbee, D., Pillai, A., Zoungas, S., Marre, M., Woodward, M., Neal, B., Chalmers, J. (2011). Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE. European Journal of Cardiovascular Prevention and Rehabilitation, 18(2), 312-319. [More Information]
  • Kengne, A., Patel, A., Marre, M., Travert, F., Lievre, M., Zoungas, S., Chalmers, J., Colagiuri, S., Grobbee, D., Hamet, P., Neal, B., Woodward, M., et al (2011). Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. European Journal of Cardiovascular Prevention and Rehabilitation, 18(3), 393-398. [More Information]
  • Woodward, M., Patel, A., Zoungas, S., Liu, L., Pan, C., Poulter, N., Januszewicz, A., Tandon, N., Joshi, P., Heller, S., Neal, B., Chalmers, J. (2011). Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial. Diabetes Care, 34(12), 2491-2495. [More Information]
  • Arima, H., Anderson, C., Omae, T., Woodward, M., Hata, J., Murakami, Y., MacMahon, S., Neal, B., Chalmers, J., PROGRESS Collaborative Group, -. (2011). Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial. Stroke, 42(8), 2339-2341. [More Information]
  • Turnbull, F., Arima, H., Heeley, E., Cass, A., Chalmers, J., Morgan, C., Patel, A., Peiris, D., Weekes, A., Anderson, C. (2011). Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study. European Journal of Cardiovascular Prevention and Rehabilitation, 18(3), 498-503. [More Information]
  • Stefansdottir, G., Zoungas, S., Chalmers, J., Kengne, A., Knol, M., Leufkens, H., Patel, A., Woodward, M., Grobbee, D., De Bruin, M. (2011). Intensive glucose control and risk of cancer in patients with type 2 diabetes. Diabetologia: clinical and experimental diabetes and metabolism, 54(7), 1608-1614. [More Information]
  • Chalmers, J. (2011). Is a Blood Pressure Target of <130/80 mm Hg Still Appropriate for High-Risk Patients? Circulation, 124(16), 1700-1702. [More Information]
  • Lee, P., Kengne, A., Greenfield, J., Day, R., Chalmers, J., Ho, K. (2011). Metabolic sequelae of beta-blocker therapy: weighing in on the obesity epidemic? International Journal of Obesity, 35(11), 1395-1403. [More Information]
  • Arima, H., Barzi, F., Chalmers, J. (2011). Mortality patterns in hypertension. Journal of Hypertension, 29(SUPPL. 1), S3-S7. [More Information]
  • Chalmers, J., Kengne, A. (2011). Predictive factors in assessing cardiovascular risk: learning from ADVANCE. Medicographia, 33(1), 47-51.
  • Arima, H., Chalmers, J. (2011). PROGRESS: Prevention of recurrent stroke. Journal of Clinical Hypertension, 13(9), 693-702. [More Information]
  • Hackam, D., Woodward, M., Newby, L., Bhatt, D., Shao, M., Smith, E., Donner, A., Muhammad, M., Douketis, J., Arima, H., Chalmers, J., MacMahon, S., et al (2011). Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-analysis. Circulation, 124(20), 2233-2242. [More Information]
  • Arima, H., Chalmers, J. (2011). Stroke: Blood pressure lowering in acute stroke-scant joy from SCAST. Nature Reviews Cardiology, 8(7), 366-368. [More Information]
  • Czernichow, S., Zanchetti, A., Turnbull, F., Barzi, F., Ninomiya, T., Kengne, A., Heerspink, H., Perkovic, V., Huxley, R., Arima, H., Patel, A., Chalmers, J., Woodward, M., MacMahon, S., Neal, B. (2011). The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. Journal of Hypertension, 29(1), 4-16. [More Information]

2010

  • Jardine, M., Ninomiya, T., Perkovic, V., Cass, A., Turnbull, F., Gallagher, M., Zoungas, S., Heerspink, H., Chalmers, J., Zanchetti, A. (2010). Aspirin is beneficial in hypertensive patients with chronic kidney disease a post-hoc subgroup analysis of a randomized controlled trial. Journal of the American College of Cardiology, 56(12), 956-965. [More Information]
  • Lee, C., Stolk, R., Adler, A., Patel, A., Chalmers, J., Neal, B., Poulter, N., Harrap, S., Woodward, M., Marre, M., et al (2010). Association between alcohol consumption and diabetic retinopathy and visual acuity-the AdRem Study. Diabetic Medicine, 27(10), 1130-1137. [More Information]
  • Heeley, E., Peiris, D., Patel, A., Cass, A., Weekes, A., Morgan, C., Anderson, C., Chalmers, J. (2010). Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Medical Journal of Australia, 192(5), 254-259. [More Information]
  • Glasziou, P., Clarke, P., Alexander, J., Rajmokan, M., Beller, E., Woodward, M., Chalmers, J., Poulter, N., Patel, A. (2010). Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis. Medical Journal of Australia, 193(6), 320-324. [More Information]
  • Head, G., Mihailidou, A., Duggan, K., Beilin, L., Berry, N., Brown, M., Bune, A., Cowley, D., Chalmers, J., Howe, P., et al (2010). Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ: British Medical Journal, 340(c1104), 1-8. [More Information]
  • Lambers Heerspink, H., Ninomiya, T., Perkovic, V., Woodward, M., Zoungas, S., Cass, A., Cooper, M., Grobbee, D., Mancia, G., Mogensen, C., Neal, B., Chalmers, J. (2010). Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. European Heart Journal, doi:10.1093/eurheartj/ehq139, 1-9. [More Information]
  • Anderson, C., Huang, Y., Arima, H., Heeley, E., Skulina, C., Parsons, M., Peng, B., Li, Q., Su, S., Tao, Q., Chalmers, J., et al (2010). Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial(INTERACT). Stroke: a journal of cerebral circulation, 41(2), 307-312. [More Information]
  • Neal, B., Jun, M., Foote, C., Lv, J., Patel, A., Nicholls, S., Grobbee, D., Cass, A., Chalmers, J., Perkovic, V. (2010). Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. The Lancet, 375(9729), 1875-1884. [More Information]
  • Arima, H., Tzourio, C., Anderson, C., Woodward, M., Bousser, M., MacMahon, S., Neal, B., Chalmers, J. (2010). Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy. The PROGRESS Trial. Stroke: a journal of cerebral circulation, 41(2), 394-396. [More Information]
  • Ninomiya, T., Zoungas, S., Neal, B., Woodward, M., Patel, A., Perkovic, V., Cass, A., Cooper, M., Grobbee, D., Hamet, P., Rodgers, A., MacMahon, S., Chalmers, J., et al (2010). Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. Journal of Hypertension, 28(6), 1141-1149. [More Information]
  • Batty, G., Li, Q., Czernichow, S., Neal, B., Zoungas, S., Huxley, R., Patel, A., de Galan, B., Woodward, M., Hamet, P., Chalmers, J., et al (2010). Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) Trial. Journal of the American College of Cardiology, 56(23), 1908-1913. [More Information]
  • Patel, A., Neal, B., Chalmers, J. (2010). Event rates in trials of patients with type 2 diabetes. JAMA, 303(8), 732. [More Information]
  • Clarke, P., Glasziou, P., Patel, A., Chalmers, J., Woodward, M., Harrap, S., Salomon, J. (2010). Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Medicine, 7(2), e1000236-1-e1000236-10. [More Information]
  • Brugts, J., Isaacs, A., Boersma, E., van Duijn, C., Uitterlinden, A., Remme, W., Bertrand, M., Ninomiya, T., Ceconi, C., Chalmers, J., MacMahon, S., et al (2010). Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. European Heart Journal, 31(15), 1854-1864. [More Information]
  • Czernichow, S., Ninomiya, T., Huxley, R., Kengne, A., Batty, G., Grobbee, D., Woodward, M., Neal, B., Chalmers, J. (2010). Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial. Hypertension, 55(5), 1193-1198. [More Information]
  • Chalmers, J., Arima, H. (2010). Importance of Blood Pressure Lowering in Type 2 Diabetes: Focus on ADVANCE. Journal of Cardiovascular Pharmacology, 55(4), 340-347. [More Information]
  • Chalmers, J., Harrap, S., Narkiewicz, K., Poulter, N., Redon, J., Zanchetti, A., Mancia, G. (2010). Issues in the development of new combinations of blood pressure lowering drugs. Journal of Hypertension, 28(12), 2494-2496.
  • Arima, H., Anderson, C., Wang, J., Huang, Y., Heeley, E., Neal, B., Woodward, M., Skulina, C., Parsons, M., Peng, B., Chalmers, J., et al (2010). Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage. Hypertension, 56, 852-858. [More Information]
  • Li, Q., Chalmers, J., Czernichow, S., Neal, B., Taylor, B., Zoungas, S., Poulter, N., Woodward, M., Patel, A., de Galan, B., et al (2010). Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Diabetologia: clinical and experimental diabetes and metabolism, 53(11), 2320-2327. [More Information]
  • Arima, H., Anderson, C., Omae, T., Liu, L., Tzourio, C., Woodward, M., MacMahon, S., Neal, B., Rodgers, A., Chalmers, J. (2010). Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. Journal of Hypertension, 28(2), 395-400. [More Information]
  • Chalmers, J., Cooper, M., Grobbee, R., Hamet, P., Kengne, A., MacMahon, S., Marre, M., Mogensen, C., Neal, B., Patel, A., et al (2010). Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure Peterax and Diamicron MR. In J Chalmers (Eds.), Action in Diabetes and Vascular Disease: Preterax and Diamicron Mr Controlled Evaluation. France: Wolters Kluwer Health France.
  • Zoungas, S., Patel, A., Chalmers, J., de Galan, B., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Kengne, A., et al (2010). Severe hypoglycemia and risks of vascular events and death. New England Journal of Medicine, 363(15), 1410-1418. [More Information]
  • Zoungas, S., Chalmers, J., Kengne, A., Pillai, A., Billot, L., de Galan, B., Marre, M., Neal, B., Harrap, S., Poulter, N., Patel, A. (2010). The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial. Diabetes Research and Clinical Practice, 89(2), 126-133. [More Information]
  • Kengne, A., Patel, A., Colagiuri, S., Heller, S., Hamet, P., Marre, M., Pan, C., Zoungas, S., Grobbee, D., Neal, B., Chalmers, J., Woodward, M. (2010). The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia: clinical and experimental diabetes and metabolism, 53(5), 821-831. [More Information]
  • Delcourt, C., Huang, Y., Wang, J., Heeley, E., Lindley, R., Stapf, C., Tzourio, C., Arima, H., Parsons, M., Sun, J., Neal, B., Chalmers, J., Anderson, C. (2010). The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). International Journal of Stroke, 5(2), 110-116. [More Information]

2009

  • Patel, A., Chalmers, J., MacMahon, S., Neal, B. (2009). ADVANCE: Blood Pressure Lowering in Diabetes (Letter to the Editor). Journal of Clinical Hypertension, 11(2), 108-108. [More Information]
  • Ninomiya, T., Perkovic, V., de Galan, B., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., Woodward, M., MacMahon, S., Chalmers, J., et al (2009). Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes. Journal of the American Society of Nephrology, 20(8), 1813-1821. [More Information]
  • Tavakoli, M., Pumford, N., Woodward, M., Doney, A., Chalmers, J., MacMahon, S., MacWalter, R. (2009). An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. The European Journal of Health Economics, 10, 111-119. [More Information]
  • Kengne, A., Czernichow, S., Huxley, R., Grobbee, D., Woodward, M., Neal, B., Zoungas, S., Cooper, M., Glasziou, P., Hamat, P., Chalmers, J., et al (2009). Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE. Hypertension, 54(2), 399-404. [More Information]
  • Zoungas, S., Chalmers, J., Patel, A. (2009). Cardiovascular Risk in Type 2 Diabetes - Reflecting on the ADVANCE Study. European Endocrinology, 5(1), 42-46.
  • Zoungas, S., Chalmers, J., Patel, A. (2009). Cardiovascular risk in Type 2 diabetes - reflecting on the ADVANCE study. U S Endocrinology, 5(1), 95-99.
  • Zoungas, S., Chalmers, J., Patel, A. (2009). Cardiovascular Risk in Type 2 Diabetes?Reflecting on the ADVANCE Study. U S Endocrinology, 5(1), 95-99.
  • de Galan, B., Zoungas, S., Chalmers, J., Anderson, C., Dufouil, C., Pillai, A., Cooper, M., Grobbee, D., Hackett, M., Hamet, P., MacMahon, S., Neal, B., Patel, A., Woodward, M., et al (2009). Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia: clinical and experimental diabetes and metabolism, 52(11), 2328-2336. [More Information]
  • Ninomiya, T., Donnan, G., Anderson, N., Bladin, C., Chambers, B., Gordon, G., Sharpe, N., Chalmers, J., Woodward, M., Neal, B. (2009). Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). Stroke: a journal of cerebral circulation, 40(6), 2111-2115. [More Information]
  • Czernichow, S., Lee, C., Barzi, F., Greenfield, J., Baur, L., Chalmers, J., Woodward, M., Huxley, R. (2009). Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials. Obesity Reviews, Online, 1-9. [More Information]
  • Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., Marre, M., Cooper, M., Glasziou, P., Grobbee, D., Joshi, R., et al (2009). Intensive blood glucose control on vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358(24), 2560-2572. [More Information]
  • Turnbull, F., Abraira, C., Anderson, R., Byington, R., Chalmers, J., Duckworth, W., Evans, G., Gerstein, H., Holman, R., Moritz, T., Neal, B., Ninomiya, T., Patel, A., Woodward, M., et al (2009). Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia: clinical and experimental diabetes and metabolism, 52(11), 2288-2298. [More Information]
  • de Galan, B., Perkovic, V., Ninomiya, T., Pillai, A., Patel, A., Cass, A., Neal, B., Poulter, N., Harrap, S., Mogensen, C., Woodward, M., MacMahon, S., Chalmers, J., et al (2009). Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes. Journal of the American Society of Nephrology, 20(4), 883-892. [More Information]
  • Chalmers, J., Arima, H. (2009). Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials. Polskie Archiwum Medycyny Wewnetrznej, 119(6), 373-380. [More Information]
  • Ninomiya, T., Perkovic, V., Verdon, C., Barzi, F., Cass, A., Gallagher, M., Jardine, M., Anderson, C., Chalmers, J., Craig, J., Huxley, R. (2009). Proteinuria and Stroke: A Meta-analysis of Cohort Studies. American Journal of Kidney Diseases, 53(3), 417-425. [More Information]
  • Perkovic, V., Ninomiya, T., MacMahon, S., Chalmers, J. (2009). Renal and microalbuminuria data from ADVANCE. In Bernard I. Levy, Harry A.J. Struijker-Boudier (Eds.), Role of Macro and Microcirculation in Target Organ Damage in Diabetes and Hypertension, (pp. 121-132). West Sussex: Wiley-Blackwell Publishing.
  • Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., Patel, A., et al (2009). Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. European Heart Journal, 30, 1128-1135. [More Information]
  • Joshi, R., de Galan, B., Chalmers, J., Perkovic, V., Patel, A. (2009). Routine blood pressure lowering and intense glucose control in patients with type 2 diabetes: results from the ADVANCE trial. Expert Review of Endocrinology and Metabolism, 4(2), 111-118.
  • Dufouil, C., Godin, O., Chalmers, J., Coskun, O., MacMahon, S., Tzourio-Mazoyer, N., Bousser, M., Anderson, C., Mazoyer, B., Tzourio, C. (2009). Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke: a journal of cerebral circulation, 40(6), 2219-2221. [More Information]
  • Arima, H., Wang, J., Huang, Y., Heeley, E., Skulina, C., Parsons, M., Peng, B., Li, Q., Su, S., Tao, Q., Chalmers, J., Anderson, C., et al (2009). Significance of perihematomal edema in acute intracerebral hemorrhage: The INTERACT trial. Neurology, 73(23), 1963-1968. [More Information]
  • Zoungas, S., de Galan, B., Ninomiya, T., Grobbee, D., Hamet, P., Heller, S., MacMahon, S., Marre, M., Neal, B., Patel, A., Woodward, M., Chalmers, J. (2009). The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care, 32(11), 2068-2074. [More Information]
  • Brugts, J., Ninomiya, T., Boersma, E., Remme, W., Bertrand, M., Ferrari, R., Fox, K., MacMahon, S., Chalmers, J., Simoons, M. (2009). The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. European Heart Journal, 30(11), 1385-1394. [More Information]

2008

  • Chalmers, J., Joshi, R., Patel, A. (2008). Advances in reducing the burden of ascular disease in type 2 diabetes. Clinical and Experimental Pharmacology and Physiology, 35, 434-437. [More Information]
  • Chockalingham, A., Chalmers, J., Whitworth, J., Erdine, S., Mancia, G., Mendis, S., Heagerty, A. (2008). Antalya statement of the International Society of Hypertension on the prevention of blood pressure-related diseases. Journal of Hypertension, 26, 2255-2258. [More Information]
  • Tzourio, C., Arima, H., Harrap, S., Anderson, C., Godin, O., Woodward, M., Neal, B., Bousser, M., Chalmers, J., Cambien, F., MacMahon, S. (2008). APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology, 70(16 (Part 1-2)), 1322-1328. [More Information]
  • Welsh, P., Lowe, G., Chalmers, J., Campbell, D., Rumley, A., Neal, B., MacMahon, S., Woodward, M. (2008). Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke. Stroke: a journal of cerebral circulation, 39, 2226-2230. [More Information]
  • Chalmers, J., Joshi, R., Kengne, A., MacMahon, S. (2008). Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE. Journal of Hypertension, 26(suppl 2), S11-S15. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2008). Can NT-proBNP Monitoring Help Prevent Cardiovascular Disease? 13th World Congress on Heart Disease, Italy: Medimond International Proceedings.
  • Turnbull, F., Woodward, M., Neal, B., Barzi, F., Ninomiya, T., Chalmers, J., Perkovic, V., Li, N., MacMahon, S. (2008). Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. European Heart Journal, 29(21), 2669-2680. [More Information]
  • Turnbull, F., Neal, B., Ninomiya, T., Algert, C., Arima, H., Barzi, F., Bulpitt, C., Chalmers, J., Fagard, R., Gleason, A., Heritier, S., Perkovic, V., Woodward, M., MacMahon, S., et al (2008). Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ: British Medical Journal, 336(6753), 1121-1123. [More Information]
  • Chalmers, J., Joshi, R., Kengne, A., Ninomiya, T., Bi, Y., Bompoint, S., Billot, L., Patel, A. (2008). Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence. Journal of Hypertension, 26(Suppl 3), S21-S27. [More Information]
  • Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., Marre, M., Cooper, M., Glasziou, P., Grobbee, D., Joshi, R., et al (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358(24), 2560-2572. [More Information]
  • Anderson, C., Huang, Y., Wang, J., Arima, H., Neal, B., Peng, B., Heeley, E., Skulina, C., Parsons, M., Jong, S., Heritier, S., Chalmers, J., et al (2008). Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurology, 7(5), 391-399. [More Information]
  • Patel, A., MacMahon, S., Chalmers, J. (2008). Intensive glucose control in type 2 diabetes - the author's reply. New England Journal of Medicine, 359, 1519-21.
  • Chalmers, J., Zhang, J. (2008). Introduction: Advances in the prevention of cardiovascular disease in patients with diabetes. Journal of Hypertension, 26, S1-2. [More Information]
  • Ninomiya, T., Perkovic, V., Gallagher, M., Jardine, M., Cass, A., Arima, H., Anderson, C., Neal, B., Woodward, M., Omae, T., MacMahon, S., Chalmers, J. (2008). Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial. Kidney International, 73(8), 963-970. [More Information]
  • Wu, Y., Huxley, R., Li, L., Anna, V., Xie, G., Yao, C., Woodward, M., Li, X., Chalmers, J., Gao, R., et al (2008). Prevalence, Awareness, Treatment, and Control of Hypertension in China: Data from the China National Nutrition and Health Survey 2002. Circulation, 118(25), 2679-2686. [More Information]
  • Chalmers, J. (2008). Prevention of stroke and major cardiovascular events with perindopril-based treatment: the PROGRESS trial. In R. Ferrari and K. M. Fox (Eds.), Perindopril: a major contribution to the prevention and treatment of cardiovascular disease, (pp. 47-58). France: Wolters Kluwer Health Pharma Solutions.
  • Chalmers, J., Colagiuri, S., Cooper, M., Grobbee, R., Hamet, P., Kengne, A., MacMahon, S., Marre, M., Mogensen, C., Neal, B., Patel, A., Perkovic, V., et al (2008). Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR. France: Wolters Kluwer Health France.
  • Patel, A., MacMahon, S., Billot, L., Chalmers, J. (2008). The ADVANCE Trial - the author's reply. The Lancet, 371(9606), 25-26.
  • Perkovic, V., Verdon, C., Ninomiya, T., Barzi, F., Cass, A., Patel, A., Jardine, M., Gallagher, M., Turnbull, F., Chalmers, J., Craig, J., Huxley, R. (2008). The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Medicine, 5(10), 1486-1495. [More Information]
  • Chalmers, J., Cooper, M. (2008). UKPDS and the legacy effect. The New England Journal of Medicine, 359(15), 1618-20. [More Information]

2007

  • Chalmers, J. (2007). ADVANCE: New Approaches for the prevention of Vascular Disease in Type 2 Diabetes. Issue 1. France: Wolters Kluwer Health France.
  • Turnbull, F., Neal, B., Pfeffer, M., Kostis, J., Algert, C., Woodward, M., Chalmers, J., Zanchetti, A., MacMahon, S. (2007). Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. Journal of Hypertension, 25(5), 951-958. [More Information]
  • Perkovic, V., Ninomiya, T., Arima, H., Jardine, M., Cass, A., Neal, B., MacMahon, S., Chalmers, J. (2007). Chronic Kidney Disease, Cardiovascular Events, and The Effects Of Perindopril-Based Blood Pressure Lowering: Data From The PROGRESS Study. Journal of the American Society of Nephrology, 18(10), 2766-2772. [More Information]
  • Patel, A., MacMahon, S., Chalmers, J., Neal, B., Woodward, M., Billot, L., Harrap, S., Poulter, N., Marre, M., Cooper, M., Glasziou, P., Grobbee, D., Rodgers, A., et al (2007). Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet, 370(September 8), 829-840.
  • Chalmers, J., Zhang, J. (2007). Introduction. Journal of Hypertension, 25, S1-2. [More Information]
  • Campbell, D., Neal, B., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S., Woodward, M. (2007). Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14(3), 413-418. [More Information]
  • Chalmers, J., Colagiuri, S., Grobbee, R., Hamet, P., Kengne, A., MacMahon, S., Mogensen, C., Neal, B., Patel, A., Perkovic, V., et al (2007). New approaches for the prevention of vascular disease in type 2 diabetes: benefits of blood pressure lowering with the fixed combination of perindopril and indapamide. France: Wolters Kluwer Health Pharma Solutions.
  • Chalmers, J., Kengne, A., Joshi, R., Perkovic, V., Patel, A. (2007). New insights from ADVANCE. Journal of Hypertension, 25(Suppl. 1), S23-S30. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2007). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in subjects with cerebrovascular disease. Journal of Hypertension, 25(3), 699-705. [More Information]

2006

  • Chalmers, J., Perkovic, V., Joshi, R., Patel, A. (2006). ADVANCE: breaking new ground in type 2 diabetes. Journal of Hypertension, 24(Supplement 5), S22-S28. [More Information]
  • Perkovic, V., Joshi, R., Patel, A., Bompoint, S., Chalmers, J., Neal, B., MacMahon, S., Glasziou, P., Woodward, M., Cooper, M., et al (2006). ADVANCE: Lessons from the run-in phase of a large study in type 2 diabetes. Blood Pressure, 15(6), 340-346. [More Information]
  • Chalmers, J. (2006). Blood pressure and stroke: a continuing debate. Journal of Hypertension, 24(7), 1249-51. [More Information]
  • Chalmers, J., Turnbull, F. (2006). Blood Pressure Lowering in Patients with a Previous Stroke. In Mohler E; Townsend R (Eds.), Advanced Therapy in Hypertension and Vascular Disease, (pp. 130-135). Ontario, Canada: BC Decker Inc.
  • Chapman, N., Anderson, C., Chalmers, J. (2006). Cerebrovascular Disease in Hypertension. In Henry R. Black, William J. Elliott (Eds.), Hypertension: A Companion to Braunwald's Heart Disease, (pp. 392-405). Saunders Elsevier.
  • Gallagher, M., Perkovic, V., Chalmers, J. (2006). Diuretics: A modern day treatment option? (Review Article). Nephrology, 11(5), 419-427. [More Information]
  • Arima, H., Chalmers, J., Woodward, M., Anderson, C., Rodgers, A., Davis, S., MacMahon, S., Neal, B., PROGRESS, C. (2006). Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. Journal of Hypertension, 24(6), 1201-1208. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S. (2006). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease. European Heart Journal, 27(Suppl 1), 781.
  • Arima, H., Tzourio, C., Butcher, K., Anderson, C., Bousser, M., Lees, K., Reid, J., Omae, T., Woodward, M., MacMahon, S., Chalmers, J. (2006). Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial. Stroke: a journal of cerebral circulation, 37(6), 1497-1502. [More Information]
  • Arima, H., Chalmers, J. (2006). Secondary prevention of stroke by blood pressure-lowering treatment. Current Hypertension Reports, 8(4), 317-323. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2006). Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. JAMA Neurology, 63(1), 60-65. [More Information]

2005

  • Chalmers, J., MacMahon, S., Colman, S., Heller, S., Neal, B., Pan, C., Patel, A., Woodward, M., Cooper, M., Adams, M., Fulcher, G., Mitchell, P., Pollock, C., Watson, J., et al (2005). ADVANCE - Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline. Diabetic Medicine, 22(7), 882-888.
  • Patel, A., Chalmers, J., Poulter, N. (2005). ADVANCE: action in diabetes and vascular disease. Journal of Human Hypertension, 19(Suppl 1), S27-S32. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Neal, B., Patel, A., MacMahon, S. (2005). Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons. European Heart Journal, 26(Suppl 1), 257.
  • Woodward, M., Lowe, G., Campbell, D., Colman, S., Rumley, A., Chalmers, J., Neal, B., Patel, A., Jenkins, A., Kemp, B., MacMahon, S. (2005). Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke. Stroke: a journal of cerebral circulation, 36(10), 2143-2147. [More Information]
  • Chalmers, J. (2005). Blood pressure in acute stroke: in search of evidence. Journal of Hypertension, 23(2), 277-8. [More Information]
  • Dufouil, C., Chalmers, J., Coskun, O., Besancon, V., Bousser, M., Guillon, P., MacMahon, S., Mazoyer, B., Neal, B., Woodward, M., Tzourio, C., et al (2005). Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation, 112(11), 1644-1650. [More Information]
  • Turnbull, F., Neal, B., Algert, C., Chalmers, J., Chapman, N., Cutler, J., Woodward, M., MacMahon, S. (2005). Effects of Different Blood Pressure-Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus: Results of Prospectively Designed Overviews of Randomized Trials. Archives of Internal Medicine, 165(12), 1410-1419. [More Information]
  • Arima, H., Hart, R., Colman, S., Chalmers, J., Anderson, C., Rodgers, A., Woodward, M., MacMahon, S., Neal, B. (2005). Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack. Stroke: a journal of cerebral circulation, 36(10), 2164-2169. [More Information]
  • Patel, A., Woodward, M., Campbell, D., Sullivan, D., Colman, S., Chalmers, J., Neal, B., MacMahon, S. (2005). Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. European Heart Journal, 26(18), 1910-1915. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease. Hypertension, 45(1), 69-74.
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation, 112(1), 110-116. [More Information]

2004

  • MacMahon, S., Neal, B., Rodgers, A., Chalmers, J. (2004). Commentary: The PROGRESS trial three years later: time for more action, less distraction. BMJ: British Medical Journal, 329(7472), 970-971.
  • Chalmers, J. (2004). Comparison Of Various Blood Pressure Lowering Treatments on the Primary Prevention of Cardiovascular Outcomes in Recent Randomised Clinical Trials. Clinical and Experimental Hypertension, 26(7-8), 709-719.
  • Chalmers, J., Chapman, N. (2004). Development Of Blood Pressure Lowering Therapy: From Trials To Practice. In WH Birkenhager, JIS Robertson, A Zanchetti (Eds.), Hypertension in the Twentieth Century: Concepts and Achievements; Handbook of Hypertension, (pp. 504-525). Amsterdam, The Netherlands: Elsevier.
  • Chapman, N., Huxley, R., Anderson, C., Bousser, M., Chalmers, J., Colman, S., Davis, S., Donnan, G., MacMahon, S., Neal, B., Woodward, M., et al (2004). Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial. Stroke: a journal of cerebral circulation, 35(1), 116-121.
  • Ohkubo, T., Chapman, N., Neal, B., Woodward, M., Omae, T., Chalmers, J., Anderson, C. (2004). Effects of an Angiotensin-converting Enzyme Inhibitor-based Regimen on Pneumonia Risk. American Journal of Respiratory and Critical Care Medicine, 169(9), 1041-1045.
  • Hasegawa, Y., Yamaguchi, T., Omae, T., Woodward, M., Chalmers, J. (2004). Effects of Perindopril-Based Blood Pressure Lowering and of Patient Characteristics on the Progression of Silent Brain Infarct: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. Hypertension Research, 27(3), 147-156.
  • Berthet, K., Neal, B., MacMahon, S., Bousser, M., Colman, S., Woodward, M., Chalmers, J. (2004). Lacunar stroke in PROGRESS study. European Journal of Neurology, 11(Suppl 2), 29.
  • Chalmers, J. (2004). Nouvelles Strategies Pour Le Controle De L'Hypertension: Preuves Supplementaries En Faveur Des Associations Faiblement Dosees. (New Strategies For Hypertension Control : More Evidence For Low-Dose Combination Therapy). American Journal of Cardiovascular Drugs, 4(Supplement 1), 37-42.
  • Rodgers, A., Chapman, N., Woodward, M., Liu, L., Colman, S., Lee, A., Chalmers, J., MacMahon, S., Anderson, C. (2004). Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Journal of Hypertension, 22(3), 653-659.
  • Berthet, K., Neal, B., Chalmers, J., MacMahon, S., Bousser, M., Colman, S., Woodward, M., Anderson, C. (2004). Reductions in the Risks of Recurrent Stroke in Patients With and Without Diabetes: The PROGRESS Trial. Blood Pressure, 13(1), 7-13.
  • Chalmers, J., Morniroli, J. (2004). The Kidney and Hypertension in Diabetes Mellitus. In Carl Erik Mogensen (Eds.), Blood Pressure Lowering Treatment And The Prevention Of Stroke In The Diabetic Patient, (pp. 611-630). London: Taylor and Francis.

2003

  • MacMahon, S., Chalmers, J. (2003). Blood pressure lowering and ACE inhibition for the avoidance of cardiac and cerebral events. European Heart Journal, 24(5), 391-393.
  • Patel, A., Chalmers, J., Chaturvedi, V., Currie, R., Monaghan, H., Neal, B., MacMahon, S. (2003). Diabetes and vascular disease: A new international trial. Asian Cardiovascular and Thoracic Annals, 11(2), 180-184.
  • Patel, A., Chalmers, J., Chaturvedi, V., Currie, R., Monaghan, H., Neal, B. (2003). Diabetes and vascular disease: a new international trial. Asian Cardiovascular and Thoracic Annals, 11(2), 180-184.
  • Chaturvedi, V., Patel, A., Chalmers, J., Chapman, N., Hansson, L., MacMahon, S., Mancia, G., Neal, B., Reid, J., Sharpe, N., Woodward, M., Anderson, C., et al (2003). Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. European Heart Journal, 24(5), 475-484.
  • Fransen, M., Anderson, C., Chalmers, J., Chapman, N., Davis, S., MacMahon, S., Neal, B., Sega, R., Terent, A., Tzourio, C., Woodward, M. (2003). Effects of a Perindopril-Based Blood Pressure-Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular Disease: A Randomized Controlled Trial. Stroke: a journal of cerebral circulation, 34(10), 2333-2338.
  • Tzourio, C., Anderson, C., Chapman, N., Woodward, M., Neal, B., MacMahon, S., Chalmers, J., Lindley, R. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163(9), 1069-1075. [More Information]
  • Turnbull, F., Neal, B., Algert, C., Chalmers, J., Woodward, M., MacMahon, S. (2003). Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. The Lancet, 362(9395), 1527-1535.
  • Chalmers, J. (2003). Etude ADVANCE: objectifs, protocole et etat actuel. Drugs, 63(Special Issue 1), 39-44.
  • Chalmers, J., Todd, A., Chapman, N., Beilin, L., Davis, S., Donnan, G., Frommer, M., Huxley, R., Lenfant, C., MacMahon, S., et al (2003). International Society of hypertension (ISH): Statement on blood pressure lowering and stroke prevention. Journal of Hypertension, 21(4), 651-663.
  • Bath, P., Chalmers, J., Powers, W., Lawrie, B., Davis, S., Lenfant, C., Mancia, G., Neal, B., Whitworth, J., Zanchetti, A. (2003). International society of hypertension (ISH): Statement on the management of blood pressure in acute stroke. Journal of Hypertension, 21(4), 665-672.
  • Chalmers, J., Arnolda, L. (2003). Lowering blood pressure in 2003. Medical Journal of Australia, 179(6), 306-312.
  • Chalmers, J., MacMahon, S. (2003). Perindopril Protection Against Recurrent Stroke Study (PROGRESS) : Interpretation and implementation. Journal of Hypertension, 21(Suppl 5), S9-S14.
  • Chalmers, J., MacMahon, S., Currie, R. (2003). PROGRESS: Rationale, results and importance: Perspective from the Principle Investigators. In Teruo Omae (Eds.), How to conduct large-scaled clinical trials in Japan, (pp. 51-55). Japan: Nihon Iji Shinpo.
  • Harrap, S., Tzourio, C., Cambien, F., Poirier, O., Raoux, S., Chalmers, J., Chapman, N., Colman, S., Leguennec, S., MacMahon, S., Neal, B., Ohkubo, T., Woodward, M., Anderson, C. (2003). The ACE Gene I/D Polymorphism Is Not Associated With the Blood Pressure and Cardiovascular Benefits of ACE Inhibition. Hypertension, 42(3), 297-303.
  • Fransen, M., Anderson, C., Chalmers, J., Chapman, N., Davis, S., MacMahon, S., Neal, B., Sega, R., Terent, A., Tzourio, C., Woodward, M. (2003). The effects of a perindopril-based blood pressure lowering regimen on disability and dependency in 6,105 patients with cerebrovascular disease. A randomised controlled trial. Stroke: a journal of cerebral circulation, (DOI: 10.1161/01.STR.0000091397.81767.40), 2333-2338.
  • Chapman, N., Chalmers, J. (2003). The prevention of secondary stroke, cardiac outcomes and cognitive decline in patients with cerebrovascular disease: The PROGRESS Trial. Seminars In Cerebrovascualr Diseases and Stroke, 3(3), 171-180.
  • Chalmers, J. (2003). Trials on blood pressure-lowering and secondary stroke prevention. The American Journal of Cardiology, 91(10A), 3G-8G.

2002

  • Chalmers, J., MacMahon, S., Brass, L., Chapman, N., Gorelick, P., Neal, B. (2002). Clinician's Manual on Blood Pressure and Stroke Prevention. United Kingdom: Current Medicine Group Ltd.
  • Chalmers, J. (2002). Enhancing risk stratification in hypertensive subjects: how far should we go in routine screening for target organ damage? Journal of Hypertension, , 1255-1257.
  • Freedman, B., Brieger, D., Celermajer, D., Chalmers, J., Tofler, G., Campbell, T., Feneley, M., Marwick, T., Muller, D., Tonkin, A. (2002). Global cardiology comes to Australia: 14th World Congress of Cardiology, Sydney, 5-9 May 2002. Medical Journal of Australia, , 473-475.
  • Chalmers, J. (2002). The ABCD of anti-hypertensive therapy? Journal of Hypertension, , 1-2.
  • Chalmers, J. (2002). Treating Hypertension or Lowering Blood Pressure? Extending the Concept. Blood Pressure, , 68-70.

2001

  • Chalmers, J., Whitworth, J. (2001). A half-century of Australian health and medical research. Medical Journal of Australia, 174, 29-32.
  • Neal, B., Chapman, J., Chalmers, J., MacMahon, S., Girgis, S., Patel, A. (2001). Blood pressure and the vascular complications of diabetes. Medicographia, 23(3), 214-219.
  • Chalmers, J., Neal, B., Chapman, J., MacMahon, S., Patel, A., Girgis, S. (2001). Blood pressure lowering in diabetes: a brief review of the current evidence and description of a new trial. Clinical and Experimental Pharmacology and Physiology, 28, 1108-1111.
  • Goodchild, A., Sun, Q., Chalmers, J., Pilowsky, P., Llewellyn-Smith, I., Cunningham, A. (2001). Calbindin-Ummunoreactive neurons in the reticular formation of the rat brainstem: catecholamine content and spinal projections. The Journal of Comparative Neurology, 424, 547-562.
  • Chalmers, J., Chapman, J. (2001). Challenges for the prevention of primary and secondary stroke: the importance of lowering blood pressure and total cardiovascular risk. Blood Pressure, 10, 344-351.
  • Goodchild, A., Chalmers, J., Pilowsky, P., Phillips, J., Dubey, R., Sesiashvili, E., Takeda, M., Lipski,, J. (2001). Differential expression of catecholamine biosynthetic enzymes in the rat ventrolateral medulla. The Journal of Comparative Neurology, 431, 20-34.
  • Chalmers, J. (2001). Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us. American Journal of Hypertension, 14.
  • Chalmers, J., Chapman, J. (2001). Progress in reducing the burden of stroke. Clinical and Experimental Pharmacology and Physiology, 28, 1091-1095.
  • MacMahon, S., Neal, B., Woodward, M., Chalmers, J., Tzourio, C., Rodgers, A., Cutler, J., Ohkubo,, T., Lindley, R., Anderson, C. (2001). Randomised trail of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. The Lancet, 358, 1033-1041.
  • Chalmers, J., MacMahon, S., Neal, B., Girgis, S., Patel, A. (2001). Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Journal of Hypertension, 19 (suppl 4).
  • MacMahon, S., Rodgers, A., Neal, B., Woodward, M., Chalmers, J. (2001). REPLY: The lowering of blood pressure after stroke. The Lancet, 358(9297), 1994-1995.
  • Chalmers, J., MacMahon, S., Neal, B., Ferrannini, E., Girgis, S., Patel, A. (2001). Study rationale and design of ADVANCE: Action in diabetes and vascular disease - preterax and diamicron MR controlled evaluation. Diabetologia: clinical and experimental diabetes and metabolism, 44, 1118-1120.

To update your profile click here. For support on your academic profile contact .